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ABSTRACT 
Programmed cell death (PCD) is an essential biological process in animal 
development and tissue homeostasis that is necessary to ensure the physiological well-
being of the organism. During PCD, phagocytes facilitate the selective removal of excess, 
damaged, and potentially deleterious cells, in a multi-step engulfment process. Genetic 
studies in Drosophila melanogaster, Caenorhabditis elegans, and mammals have 
identified two evolutionarily conserved signal transduction pathways that act redundantly 
to regulate engulfment: the CED-1/-6/-7 and CED-2/-5/-12 pathways. Of these cell death 
(CED) proteins, the ABC transporter CED-7 is the only protein reported to be required in 
both the engulfing cell and the dying cell. However, its function in the cell death process 
remains the most enigmatic and the ced-7 ortholog previously has not been identified in 
Drosophila.  Homology searches revealed a family of putative ced-7 orthologs that 
encode transporters of the ABCA family in Drosophila. To determine which of these 
genes functions similarly to ced-7/ABCA1 in PCD, we analyzed their engulfment function 
  
 
in oogenesis, during which 15 germ cells in each egg chamber undergo programmed cell 
death and are removed by neighboring phagocytic follicle cells. It has been shown that 
genetically knocking down individual engulfment genes results in inefficient clearance of 
the germ cells, which then persist in late-stage egg chambers. Only two of the putative 
ced-7/ABCA1 genes are expressed significantly in the ovary, CG31731 and CG1718, and 
we have characterized these genes using transposon insertions, deficiencies, and RNAi 
knockdowns. Our genetic analysis reveals that CG31731 is necessary for germ cell 
clearance in the Drosophila ovary. Immunostaining shows that genetically knocking 
down CG31731 results in uncleared germ cells which persist in late-stage egg chambers.  
Altogether, our findings suggest that CED-7/ABCA1/CG31731 play evolutionarily 
conserved roles during engulfment.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Programmed cell death 
Programmed cell death (PCD) is an essential biological process that serves 
several physiological functions during development and homeostasis including the 
sculpting of tissues and organs, the regulation of cell turnover to balance cell 
proliferation, and the removal of damaged or deleterious cells (Jacobson et al., 1997; 
Elliott and Ravichandran, 2010; Fuchs and Steller, 2011). PCD is important in a variety 
of cells and tissues and abnormal regulation of PCD has been implicated in a wide range 
of disease pathogenesis including developmental malformations, physiological disorders, 
autoimmunity, neurodegeneration, and cancer (Elliott and Ravichandran, 2010; Fuchs 
and Steller, 2011).  
The term “programmed cell death” was initially used to describe cell deaths that 
occur in predictable places and at predictable times during development (Jacobson et al., 
1997). The current use of the term has expanded to refer to intentional cell deaths that 
occur in a controlled and regulated manner via the activation of an inherent death 
program (Jacobson et al., 1997; Fuchs and Steller, 2011). Cells undergoing PCD have 
been shown to proceed through four highly regulated steps: (1) specification of the dying 
fate, (2) execution of cell death, (3) recognition and engulfment by phagocytes, and (4) 
degradation inside the engulfing cells (Mangahas and Zhou, 2005). Although diverse 
signals can induce PCD, genetic and molecular studies in nematodes, arthropods, and 
mammals have identified a set of evolutionarily conserved cell death pathways and genes 
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that regulate each step (Jacobson et al., 1997; Elliott and Ravichandran, 2010; Fuchs and 
Steller, 2011). 
The significance and mechanisms of PCD continue to be the subject of intense 
investigation and review. To date, over a dozen cell death modalities have been 
described, including apoptosis, necrosis, autophagic cell death, and phagoptosis, each 
distinguished on the basis of distinct morphological, molecular, and genetic features 
(Kroemer et al., 2009). 
1.1.1 Apoptosis 
Apoptosis represents the best-studied form of PCD. In apoptosis, a cell 
deliberately commits suicide in response to developmental death signals or physiological 
stress, such as oxidative stress and nutrient deprivation (Steller, 2008).  When a cell 
commits to apoptosis, the apoptotic cell death pathway activates pro-apoptotic proteins 
such as cysteine aspartyl proteases (caspases), and inhibits anti-apoptotic proteins such as 
inhibitor of apoptosis (IAP) proteins. In healthy cells, IAPs prevent the activation of 
caspases. In apoptotic cells, the expression of IAP antagonists relieves caspases from 
suppression by IAPs and thereby allows their activation. Caspases serve as key 
executioners of apoptosis that specifically cleave proteins to dismantle the cell (Fuchs 
and Steller, 2011; Fuchs and Steller, 2015). As a result, apoptotic cells display 
characteristic morphological changes, such as nuclear chromatin condensation, DNA 
fragmentation, cell volume shrinkage, and plasma membrane blebbing (Kroemer et al., 
2009). During the final steps of apoptosis, the cell corpse is swiftly engulfed and 
degraded by phagocytic cells before any leakage of the cell contents occurs (Jacobson et 
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al., 1997; Steller, 2008). Over time, apoptotic cells that are not promptly cleared can lose 
their membrane integrity and become secondarily necrotic (Elliot and Ravichandran, 
2010). 
1.1.2 Necrosis/necroptosis 
Historically, necrosis has been described as a form of accidental cell death which 
results in the uncontrolled and unregulated lysis of the cell (Kroemer et al., 2009). 
However, accumulating evidence suggests that necrosis may be finely regulated by a set 
of signal transduction pathways and catabolic mechanisms. Recent research has identified 
several regulatory genes and small molecules, such as receptor interacting protein kinases 
(RIPK1 and RIPK3) and  necrostatins, and demonstrated that necrosis can proceed 
through a series of defined molecular and morphological events (Kroemer et al., 2009; 
Fuchs and Steller, 2011; Fuchs and Steller, 2015). It is speculated that the necrotic cell 
death pathway is linked to the apoptotic cell death pathway, as it becomes activated when 
the lack of caspase activity fails to activate the apoptotic signaling pathways (Fuchs and 
Steller, 2015). “Necroptosis” is now recognized as a controlled and regulated form of 
necrotic PCD characterized by chromatin clumping and organelle swelling, followed by 
cell volume swelling leading to rupturing of the plasma membrane (Kroemer et al., 2009; 
Fuchs and Steller, 2015). The subsequent release of intracellular contents, including toxic 
levels of reactive oxygen species and inflammatory cytokines, into the extracellular space 
can provoke a strong inflammatory response (Jacobson et al., 1997; Elliot and 
Ravichandran, 2010; Fuchs and Steller, 2015). Pertinently, chronic inflammation has 
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been implicated as the impetus for a variety of autoimmune disorders and tumorigenesis 
(Elliot and Ravichandran, 2010).  
1.1.3 Autophagic cell death 
The word “autophagy” derives from Ancient Greek, meaning “self-devouring”. 
Befittingly, autophagy is the cell’s intracellular degradation system, regulated by a series 
of autophagy (ATG) genes. In autophagy, double-membraned isolation vesicles surround 
and sequester targeted cytoplasmic components in the cell, forming an autophagosome 
which fuses with lysosomes to become an autolysosome, to degrade the sequestered 
cellular contents. (Kroemer et al., 2009; Mizushima and Komatsu, 2011; Nelson and 
Baehrecke, 2014; Fuchs and Steller, 2015). The role of this catabolic process is highly 
context-dependent and has been shown to serve as both a pro-survival and pro-death 
mechanism. Induction of autophagy has been mainly observed as an adaptive response to 
stress, such as nutrient deprivation, allowing cells to consume their digested components 
for energy, and recycle amino acids to promote cell survival (Mizushima and Komatsu, 
2011; Fuchs and Steller, 2015).  Conversely, recent studies have also demonstrated that 
ATG genes are required to promote certain cell deaths, for example in the Drosophila 
midgut and salivary gland. Interestingly, during PCD of the salivary gland cells, the 
autophagic cell death pathway was observed to function in parallel with the apoptotic cell 
death pathway (Kroemer et al., 2009; Nelson and Baehrecke, 2014; Fuchs and Steller, 
2015). However, in contrast to apoptosis, autophagic cells self-degraded and cleared with 
no association with phagocytic cells (Kroemer et al., 2009; Nelson and Baehrecke, 2014).  
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1.1.4 Phagoptosis 
Traditionally, PCD has been regarded as a cell-autonomous suicide program in 
which a cell controls its own demise. Recently, several non-autonomous forms of PCD 
have been described in which the death of a cell is extrinsically regulated by another cell. 
An intriguing example of non-autonomous PCD is phagoptosis, in which a phagocytic 
cell devours and directly causes the death of a cell. The cell death process requires the 
phagocytic machinery and inhibition of phagocytosis prevents the cell death. Phagoptosis 
is a relatively new concept and thus the mechanism by which phagocytic cells can “kill” 
other cells has not been fully elucidated. It has been speculated that as in engulfment, 
phagosomes in the phagocytic cell containing the viable cell may fuse with lysosomes to 
degrade the phagocytosed cell (Brown and Neher, 2012). 
1.2 Engulfment 
Engulfment represents an important step in PCD that is necessary for the selective 
removal of cells fated to die. The process prevents the accumulation of cell corpses and 
ensures that dying or dead cells are removed before they release their harmful cellular 
contents (Mangahas and Zhou, 2005; Fullard et al., 2009; Elliot and Ravichandran, 
2010). Defective engulfment and clearance mechanisms have been implicated as 
important contributing factors to the pathogenesis of inflammatory diseases such as 
chronic obstructive pulmonary disease, autoimmune diseases such as lupus, and 
neurodegenerative diseases such as Alzheimer’s disease (Elliot and Ravichandran, 2010). 
The engulfment step is generally performed by “professional” phagocytes, such as 
mammalian macrophages, whose primary function is the phagocytosis of dying cells and 
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cell corpses. In areas where professional phagocytes have little to no access, neighboring 
cells can function as “non-professional” phagocytes to remove these unnecessary cells 
(Mangahas and Zhou, 2005; Fullard et al., 2009; Elliott and Ravichandran, 2010). For 
example, C. elegans do not have professional phagocytes and engulfment is 
accomplished by neighboring cells including epidermal and muscle cells (Mangahas and 
Zhou, 2005; Fullard et al., 2009). Current evidence suggests that both professional and 
non-professional phagocytes carry out the same steps in the engulfment process (Elliott 
and Ravichandran, 2010). 
The engulfment process can be described as a succession of 3 steps: (1) 
recruitment of phagocytes to the dying cells, (2) recognition of the dying cells by the 
phagocytes, and (3) internalization of the cell corpse by the phagocytes (Figure 1.1). In 
the early stages of PCD, dying cells secrete “find-me” signals, soluble chemoattractants 
that are sensed by and promote chemotaxis of motile phagocytes to the dying cells. Once 
in proximity of the dying cells, phagocytes can recognize and bind “eat-me” signals, such 
as phosphatidylserine (PtdSer), on the surface of dying cells. The physical engagement 
initiates a signal transduction cascade within the phagocytes that stimulates cytoskeletal 
rearrangements and extensions of a phagocytic cup around the cell corpse for its 
internalization and engulfment (Fullard et al., 2009; Elliott and Ravichandran, 2010). The 
entire process is tightly regulated by a common engulfment mechanism that has been 
evolutionarily conserved from nematodes to humans. 
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1.2.1 Identification of engulfment genes 
Initial studies in C. elegans identified seven ced (cell death abnormal) genes: ced-
1, ced-2, ced-5, ced-6, ced-7, ced-10, ced-12, that are involved in the engulfment process. 
Mutations in any of these genes in the phagocytic cell negatively affect engulfment and 
result in the accumulation of persisting cell corpses (Kinchen et al. 2005; Mangahas and 
Zhou, 2005; Fullard et al., 2009). Subsequent studies in Drosophila, mice, and humans 
indicated that these seven genes and their roles in engulfment are evolutionarily 
conserved (Mangahas and Zhou, 2005; Fullard et al., 2009).  
Extensive genetic and molecular analyses in C. elegans suggest that these genes 
act in two parallel and partially redundant signaling pathways: ced-1/-6/-7 and ced-2/-5/-
12, that converge on CED-10 (Figure 1.2) (Kinchen et al., 2005; Mangahas and Zhou, 
2005; Fullard et al., 2009).  Single or double mutants within the same pathway display 
weaker phenotypes than double mutants between the two pathways. Whereas double 
mutants within the same pathway show engulfment defects no more severe than that of 
the stronger single mutant, double mutants between the two pathways show engulfment 
defects much more severe than that of either of the single mutants (Mangahas and Zhou, 
2005). Moreover, double mutants between the two pathways show similar engulfment 
defects to that of ced-10 mutants, and can be genetically rescued, with a reduction in the 
number of persisting cell corpses, following ced-10 induction (Kinchen et al., 2005). 
Triple mutants do not display a stronger phenotype than any of the double mutants, 
suggesting that none of the seven genes act in a third pathway (Ellis et al., 1991). The 
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results of these studies are consistent with the model that the engulfment genes act in two 
parallel and partially redundant engulfment pathways that converge on CED-10.  
1.2.2 ced-10 (Rac1) 
ced-10 encodes a homolog of the human Rac1, a small GTPase responsible for the 
cytoskeletal rearrangements that allow for the internalization of the cell corpse (Reddien 
and Horvitz, 2000). Consistent with the notion that CED-10 is required for cytoskeleton 
reorganization, ced-10 mutants suffer from cell migration defects (Reddien and Horvitz, 
2000; Kinchen et al., 2005). The Rac family of small GTPases has been demonstrated to 
act as molecular switches on the plasma membrane to regulate actin cytoskeleton 
rearrangements. In its inactive state, Rac-GDP is sequestered in the cytoplasm with 
minimal GTPase activity. Upon guanine exchange factor (GEF)-mediated GDP-to-GTP 
exchange, Rac-GTP exposes a prenyl group that anchors the enzyme to the plasma 
membrane. Active Rac-GTP catalyzes the local reorganization of the actin cytoskeleton 
to facilitate extensions of the plasma membrane (Chimini and Chavrier, 2000).  
1.2.3 ced-2/-5/-12 (CrkII/DOCK180/ELMO) pathway 
The ced-2/-5/-12 pathway has been relatively well-characterized since the 
pathway is also essential for multiple cell migration events (Reddien and Horvitz, 2000; 
Gumienny et al., 2001). Respectively, ced-2, ced-5, ced-12 represent the C. elgeans 
homologs of the mammalian CrkII, DOCK180, ELMO genes. Sequence analyses 
indicates that ced-2/CrkII encodes an adaptor protein possessing several Src homology 
(SH) domains, SH2 and SH3; ced-5/DOCK180 encodes a Rac-GEF possessing a DOCK 
homology region (DHR); and ced-12/ELMO encodes another adaptor protein, possessing 
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a proline-rich SH3-binding domain and a Pleckstrin homology (PH) domain (Mangahas 
and Zhou, 2005) . 
Biochemical studies show that the SH3 domains of CED-2/CrkII can physically 
interact with CED-5/DOCK180. Furthermore, CED-5/DOCK180 and CED-12/ELMO 
can form a complex independent of CED-2/CrkII activity, and function together as a 
bipartite GEF to activate downstream CED-10/Rac1. While CED-12/ELMO alone does 
not possess any obvious catalytic domain, its PH domain was observed to possess Rac-
GEF activity in vitro when cotransfected with CED-5/DOCK180 (Gumienny et al., 2001; 
Zhou et al., 2001; Brugnera et al., 2002; Lu et al., 2004). Additionally, assays performed 
using cultured mammalian cells revealed the formation of a CrkII-DOCK180-ELMO 
trimeric complex, most likely through DOCK180 bridging CrkII and ELMO (Gumienny 
et al., 2001). However, it is not clear whether the trimeric complex cooperatively 
functions to activate Rac1 or whether CrkII only transiently interacts with the DOCK180-
ELMO complex. By analogy, these assays suggest that in C. elegans, CED-2 similarly 
associates with CED-5–CED-12 to form a trimeric complex upstream of CED-10 
activation.  
It has been proposed that CED-2 recruits the CED-5–CED-12 GEF complex to 
the plasma membrane where it can facilitate GTP-loading onto CED-10 to promote 
cytoskeletal rearrangements (Mangahas and Zhou, 2005). Consistent with this hypothesis, 
the mammalian DOCK180 DHR domain can bind phosphatidylinositols (PtdIns), 
specifically PtdIns(3,5)P2 and PtdIns(3,4,5)P3, on the inner leaflet of the plasma 
membrane (Côté et al., 2005). While the C. elegans CED-5 DHR domain does not 
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detectably bind to any phospholipids, the CED-12 PH domain, which is required for GEF 
function with CED-5 (Gumienny et al., 2001), is observed to bind PtdIns(3,5)P2 and 
PtdIns(3,4,5)P3 (Neukomm et al., 2011). Both the DOCK180 DHR domain and CED-12 
PH domain is necessary for cytoskeletal rearrangements at the plasma membrane, 
suggesting that they mediate a PtdIns-dependent translocation of the GEF complexes to 
the plasma membrane for activation of CED-10/Rac1 and subsequent reorganization of 
the actin cytoskeleton (Côté et al., 2005; Neukomm et al., 2011). 
Several upstream activators of the CED-2/-5/-12 pathway have been identified, 
including integrin α (INA-1). INA-1 is an engulfment receptor that recognizes dying cells 
and indirectly transduces the engulfment signal to the CED-2/-5/-12 pathway. SRC-1, a 
non-receptor tyrosine kinase, likely serves as the bridging molecule linking INA-1 to 
CED-2, as observed by SRC-1 binding to both the INA-1 cytoplasmic domain and CED-
2. Moreover, INA-1 and SRC-1 colocalize at the phagocytic cup, suggesting that upon 
recognizing dying cells, INA-1 with SRC-1 recruits the CED-2–CED-5–CED-12 
signaling module to promote activation of CED-10, which leads to the cytoskeletal 
rearrangements necessary for formation of a phagocytic cup (Hsu and Wu, 2010).  
In mammalian cell culture, integrin αvβ5 was similarly implicated as an upstream 
receptor that indirectly transduces extracellular signals to the CrkII-DOCK180-ELMO 
Rac-activating complex through p130cas, which interacts with CrkII (Albert et. al., 2000). 
These similarities between the C. elegans and mammalian engulfment pathways confirm 
an evolutionarily conserved mechanism that regulates cytoskeletal reorganization in 
phagocytic cells. 
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1.2.4 ced-1/-6/-7 (MEGF10/GULP/ABCA1) pathway 
The ced-1/-6/-7 pathway is more complex and less understood. To begin with, 
several mammalian homologs have been proposed for some genes: MEGF10, JEDI, and 
LRP1 for ced-1; GULP for ced-6; ABCA1 and ABCA7 for ced-7 (Mangahas and Zhou, 
2005; Kinchen and Ravichandran, 2007). These genes have been shown to differentially 
mediate multiple downstream activities, including CED-10/Rac1 activation, PtdSer 
exposure, and intracellular vesicle delivery (Hamon et al., 2000; Kinchen et al., 2005; Yu 
et al., 2006), although some of these activities are controversial (Mangahas and Zhou, 
2005; Mapes et al., 2012). Until very recently, no upstream activating signals had been 
described. The lack of collective data has made it difficult to define the precise role and 
mechanism of this evolutionarily conserved engulfment pathway. 
The best characterized gene in the pathway, ced-1, encodes a single-pass 
transmembrane receptor with a large extracellular region boasting 16 tandem copies of 
EGF-like repeats, and an intracellular region containing a functionally necessary SH2-
binding and  PTB-binding domain (Zhou et al., 2001). Its mammalian orthologs, 
MEGF10 and JEDI, display extensive structural and sequence similarities to CED-1 
throughout their entirety, while LRP1 presents an extracellular architecture that is 
different from that of CED-1 (Mangahas and Zhou, 2005; Scheib et al., 2012). 
Nonetheless, MEGF10, JEDI, and LRP1 serve as transmembrane scavenger receptors in 
phagocytic cells, suggesting that CED-1 may similarly function to recognize signals on 
the surface of dying cells to facilitate engulfment (Zhou et al., 2001; Scheib et al., 2012). 
Indeed, CED-1/MEGF10/JEDI have been observed to localize to the surface membrane 
 
 
12 
 
   
 
of phagocytic cells and accumulate at the phagocytic cup surrounding the dying cells 
(Zhou et al., 2001; Hamon et al., 2006; Scheib et al., 2012).  
The mechanism of CED-1/MEGF10 clustering around the cell corpse requires 
CED-7/ABCA1 (Zhou et al., 2001; Hamon et al., 2006), ATP-binding cassette (ABC) 
transporter proteins. In C. elegans, CED-7 activity is required in both the phagocytic cell 
and the dying cell for engulfment (Wu and Horvitz, 1998), which has made it 
complicated to determine exactly where in the signaling pathway CED-7 acts to promote 
CED-1 clustering. Moreover, the signaling mechanisms and functional interactions of 
CED-7 remain elusive. It is not yet known whether ABCA1 is also expressed in dying 
cells, but in mammalian cell culture, induction of ABCA1 in non-phagocytic cells is 
sufficient to confer engulfment ability in vitro (Hamon et al., 2000). Section 1.3 will 
discuss CED-7/ABCA1 in further detail.  
Recently, TTR-52, a secreted transthyretin-like protein, was also observed to 
cluster around dying cells and also promote CED-1 clustering at the phagocytic cup. 
Secreted TTR-52 was further demonstrated to facilitate CED-1 recognition of PtdSer on 
the surface of dying cells by specifically binding to PtdSer and the extracellular domain 
of CED-1 (Wang et al., 2010), suggesting TTR-52 serves as a bridging molecule for 
CED-1-mediated engulfment of dying cells. Consistent with this model, normal cells 
ectopically exposing PtdSer were phagocytosed in a ttr-52- and ced-1-dependent manner 
(Darland-Ransom et al., 2008; Wang et al., 2010). However, ttr-52 mutants only partially 
block the clustering of CED-1 around dying cells and show a weaker engulfment defect 
compared to ced-1 mutants (Wang et al., 2010), suggesting that there are likely additional 
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bridging molecules and/or “eat-me” signals that could mediate the recognition of 
apoptotic cells by CED-1.  
CED-1 has also been observed to interact with CED-6, a PTB-domain containing 
adaptor protein. Specifically, the cytoplasmic region of CED-1/LRP1 was demonstrated 
to physically associate with the PTB domain of CED-6/GULP (Su et al., 2002). CED-6 
likely acts as a signaling adaptor downstream of CED-1 and CED-7, since over-
expression of ced-6 in a ced-1 or ced-7 mutant background rescues the associated 
engulfment defects (Liu and Hengartner, 1998). Additionally, mutations in ced-6 do not 
disrupt CED-1 clustering or recognition of dying cells, which requires ced-1 and ced-7 
(Zhou et al., 2001), but do prevent downstream activities including pseudopod extensions 
and phagocytic cup formation (Yu et al., 2006). While the immediate downstream 
molecular activities of CED-6 have not been elucidated, these observations lead us to 
speculate that CED-6 functions to transduce signals from CED-1 to CED-10 to promote 
cytoskeletal rearrangements.  
Multiple cellular processes must occur in phagocytic cells for the successful 
engulfment of cell corpses including cytoskeletal rearrangements, membrane extensions, 
and membrane closure. The ced-1/-6/-7 pathway has also been implicated in promoting 
membrane extensions at the growing phagocytic cup via another GTPase, Dynamin 
(DYN-1). DYN-1 was observed to localize to the growing phagocytic cup in a ced-1-, 
ced-6-, ced-7-dependent manner (Yu et al., 2006) to facilitate intracellular recruitment 
and fusion of endosomes to the plasma membrane (Yu et al., 2008), likely to provide 
lipid and protein materials for pseudopod extensions. Live imaging studies in C. elegans 
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have also observed a role for CED-1, CED-6, and DYN-1 signaling in promoting cell 
corpse degradation via RAB-7, a small GTPase that is involved in endocytic vesicle 
trafficking. RAB-7 localizes to phagosome membranes and is required for the recruitment 
and fusion of lysosomes to phagosomes for cell corpse degradation (Yu et al., 2008). In 
support of a role for the ced-1/-6/-7 pathway in degradation, other studies have shown 
that defects in corpse degradation pathways also inhibit engulfment (Kinchen and 
Ravichandran, 2007).  
Altogether, these observations suggest that the ced-1/-6/-7 pathway may be 
involved in multiple steps during PCD including engulfment and degradation of the cell 
corpse. Nevertheless, questions remain including what are the upstream and downstream 
signaling activities of CED-6 and CED-7. Much more research is needed to clarify the 
roles and molecular mechanisms of this important signaling pathway in engulfment. 
1.2.5 Engulfment in Drosophila melanogaster 
  In Drosophila, the role of the ced-1/-6/-7 and ced-2/-5/-12 engulfment pathways 
appear to be conserved in draper/Ced-6 and Crk/mbc/Ced-12. With the exception of the 
ced-7 homolog, which has not been identified, these Drosophila genes have been shown 
to act in phagocytic cells to promote engulfment in several in vivo systems including 
phagocytic follicle cells, engulfing glia, and hemocytes (Manaka et al., 2004; Awasaki et 
al., 2006; MacDonald et al., 2006; Timmons et al., 2016). Several other components of 
the engulfment machinery have also been identified in Drosophila.  
  Draper is observed to localize to the surface membrane of phagocytic cells, facing 
the dying cells. Whether Draper recognizes PtdSer exposed on the surface of dying cells 
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is under debate (Manaka et al., 2004; Tung et al., 2013). Pretaporter, an endoplasmic 
reticulum protein also exposed on the surface of dying cells, has been proposed as 
another “eat-me” signal recognized by Draper (Kuraishi et al., 2009). Six Microns Under 
(SIMU), another transmembrane receptor, was similarly demonstrated to bind dying cells 
upstream of Draper (Kurant et al., 2008).  
  The intracellular adapter protein Ced-6 has been show to co-localize and 
genetically interact with the PTB-binding domain of Draper (Awasaki et al., 2006; 
Kuraishi et al., 2009). However, Ced-6 is not required in several engulfment processes 
including Wallerian degeneration (Lu et al., 2017) and developmental germ cell death 
(Timmons, 2015). Instead, Draper-mediated signaling events during engulfment in some 
systems seem to be dependent on Shark, a cytosolic tyrosine kinase observed to also 
interact with the cytosolic region of Draper (Ziegenfuss et al., 2008). Draper has also 
been implicated to regulate downstream Dynamin and Rab GTPases, namely Shibire, 
Rab5 and Rab7, for phagosome maturation and cell corpse degradation (Kurant et al., 
2008; Etchegaray et al., 2016; Meehan et al., 2016; Timmons et al., 2016).   
  A GEF complex formed by DRK–DOS–SOS has been shown to act downstream 
of Draper to activate the small GTPase Rac1 (Lu et al., 2014). Similarly, in a parallel 
pathway to Draper, the GEF complex formed by Crk–MBC–Ced-12 also activates Rac1 
(Geisbrecht et al., 2008; Ziegenfuss et al., 2012; Lu et al., 2014). Currently, the 
Crk/MBC/Ced-12 engulfment pathway remains relatively poorly characterized, though 
integrins have recently been proposed as an upstream engulfment receptor of the pathway 
(Meehan et al., 2016). Additionally, Ced-12 was found to be required for border cell 
 
 
16 
 
   
 
migration during oogenesis, and therefore Ced-12 deficiency mutants are sterile 
(Geisbrecht et al., 2008, Timmons et al., 2016). 
1.3 CED-7/ABCA1 
The C. elegans CED-7 engulfment protein has become something of an enigma. 
Studies with CED-7 have not been able to address its molecular function during 
engulfment. The mammalian functional equivalent remains controversial as ABCA1 
(Luciani and Chimini, 1996) and recently ABCA7 (Jehle et al., 2006) have been proposed 
as putative CED-7 mammalian homologs. Both ABCA proteins have been shown to be 
required in the engulfment of cell corpses, though the potential function of ABCA1 in 
engulfment has been better characterized. The Drosophila homolog of CED-7/ABCA1 
has not been identified.  
1.3.1 Functional Characterization of CED-7/ABCA1 
The ced-7/ABCA1/ABCA7 genes encode members of the ABCA subfamily of 
ABC transporters proteins (Wu and Horvitz, 1998; Luciani and Chimini, 1996; Jehle et 
al., 2006). ABC transporters are known to localize to membranes and utilize the energy 
from ATP hydrolysis to drive the translocation of various substrates. Mutations that 
abolish the catalytic function of CED-7 or ABCA1/7 in phagocytic cells cause 
engulfment defects that lead to the accumulation of cell corpses in vivo (Luciania and 
Chimini, 1996; Wu and Horvitz, 1998; Hamon et al., 2000; Jehle et al., 2006), identifying 
a role for these transporters in engulfment. Moreover, the induced expression of full-
length ABCA1 in non-phagocytic cell cultures confers engulfment ability (Hamon et al., 
2000). Consistent with a role for ABCA1 during PCD, the protein is highly expressed on 
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the surface of active macrophages in the hindlimb interdigital PCD zones of developing 
mice (Luciania and Chimini, 1996; Hamon et al., 2000). 
Deficiencies or loss-of-function mutations in ced-7/ABCA1 exhibit only transient 
accumulation of cell corpses in development without any embryonic lethal consequences, 
but impair reproductive capability and lifespan in adults (Wu and Horvitz, 1998; 
Mangahas and Zhou, 2005; Hamon et al., 2000). In ced-7 deficient mutants, cell corpses 
persist in developing embryos only until hatching, and then the cell corpses are rapidly 
cleared (Wu and Horvitz, 1998). This delay in cell corpse clearance is similarly observed 
in the limb bud of ABCA1-deficient developing mice, without any significant 
physiological consequences. However, homozygous ABCA1-deficient adult females 
suffered from abnormal placental development and did not produce litters. ABCA1 was 
found to be normally expressed at high levels in the placenta, where it appears to be 
important for fertility. Additionally, 4-weeks post-natal ABCA1-deficient mice exhibited 
a <25% survival rate, due to deep perivisceral hemorrhages (Hamon et al., 2000). Thus, 
functional CED-7/ABCA1 is necessary to ensure normal physiology and survival in 
adulthood. 
CED-7/ABCA7 localizes to the surface membrane and is required for efficient 
cell clearance (Wu and Horvitz, 1998; Hamon et al., 2000). Intriguingly, whereas 
ABCA1 is clearly required in phagocytic cells (Hamon et al., 2000), genetic studies in C. 
elegans indicate CED-7 is required in both the phagocytic and the dying cells for efficient 
engulfment (Wu and Horvitz, 1998). Whether ABCA1 is expressed in vivo in dying cells 
has not been determined, although ABCA1 has been shown to be able to promote several 
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events in both the engulfing and dying cells in vitro (Hamon et al., 2000). Currently, 
CED-7 is the only protein reported to be required in both cells, and may provide a link 
between the cell death execution pathway and the engulfment pathway (Mangahas and 
Zhou, 2005).  
Several separate studies support the idea that CED-7/ABCA1 function in both 
phagocytic cells and dying cells is important for cell corpse recognition by phagocytes 
(Hamon et al., 2000; Zhou et al., 2001; Yu et al., 2006). In vitro studies in red blood cells 
and thymocytes have demonstrated a requirement for ABCA1 in PtdSer exposure 
following an apoptotic stimulus. Prior to an apoptotic stimulus, wild-type and ABCA1-
deficient cells display a similar asymmetrical distribution of PtdSer across the membrane 
bilayer. Following an apoptotic stimulus such as Ca2+ stress or γ-irradiation, a two- to 
three-fold reduction in PtdSer exposure was observed in ABCA1-deficient cells compared 
to wild-type ABCA1-expressing cells. Phosphatidylcholine distribution was not affected 
in these experiments (Hamon et al., 2000). These observations suggest that ABCA1 can 
specifically promote the exposure of PtdSer in dying cells, which is necessary for cell 
corpse recognition by phagocytic cells. 
The sequence similarity between CED-7 and ABCA1 suggests that CED-7 may 
also act to promote PtdSer exposure on the surface of dying cells. This hypothesis is 
consistent with the ability of ABC transporters to serve as floppases, which can 
specifically direct the externalization of lipids, for example PtdSer (Daleke, 2003). 
However, in engulfment defective ced-7 mutants, PtdSer was clearly detected on the 
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surface of persisting cell corpses (Mapes et al., 2012), indicating that CED-7 is not 
required for the exposure of PtdSer in vivo in C. elegans.  
Alternatively, CED-7 has been proposed to mediate the exocytosis of vesicles 
containing engulfment recognition signals from dying cells to phagocytic cells. Immuno-
electron micrograph images show the presence of extracellular vesicles in wild-type C. 
elegans, which are absent in ced-7 mutants and dramatically reduced in ttr-52-mutants, 
lacking the TTR-52 bridging molecule which can facilitate CED-1 recognition of PtdSer 
(Mapes et al., 2012). Some of the extracellular vesicles were observed to contain PtdSer 
and the event is accompanied by a loss of PtdSer on the surface of dying cells and the 
acquisition of PtdSer on the phagocyte membrane. These observations suggest that the 
vesicles are exocytosed from dying cells and acquired by phagocytic cells. The presence 
of PtdSer on the surface of phagocytic cells also requires the transmembrane and 
extracellular domains of CED-1 (Mapes et al., 2012). Thus we speculate a model wherein 
CED-7 in dying cells may function to exocytose vesicles, some containing TTR-52 
targeted for exocytosis, and CED-1 at the phagocytic membrane may provide the docking 
site for vesicle fusion. The dramatic reduction, but not absence of, vesicles in ttr-52 
mutants suggests that CED-7 likely mediates the exocytosis of other molecules targeted 
for exocytosis. 
This potential role for CED-7/ABCA1 in vesicle exocytosis is consistent with the 
ability of ABCA transporters to mediate the efflux of lipids and other materials from the 
plasma membrane (Vasiliou et al., 2009). In fact, the forced expression of ABCA1 has 
been shown to promote the shuttling of certain phospholipids and cholesterol to apo-AI to 
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form high density lipoproteins (HDL) (Hamon et al., 2000). In humans, ABCA1-
deficiency is implicated in Tangier disease, a recessive disorder characterized by the lack 
of HDLs due to a defect in cellular release of lipids and cholesterol (Vasiliou et al., 
2009). The over-expression of ABCA7 in cell culture has also been shown to mediate 
phospholipid efflux, but not cholesterol, to apo-AI (Wang et al., 2003). Interestingly, 
LRP1 and GULP are also implicated in cholesterol metabolism, suggesting a potentially 
conserved role for LRP1/GULP/ABCA1 (Hengartner, 2001). 
The proposed function of CED-7 in shuttling vesicles from dying cells to 
phagocytes may explain the requirement for CED-7 in CED-1 clustering at the 
phagocytic cup (Zhou et al., 2001), where CED-1 may facilitate fusion of the shuttled 
vesicles to the phagocytic cell membrane. However, in mammalian cell cultures, where 
the expression of ABCA1 in dying cells has not been determined in vivo, the 
redistribution of MEGF10 at the phagocytic cup is sensitive to the presence of ABCA1 in 
phagocytic cells (Hamon et al., 2006). It has been proposed that CED-7/ABCA1 in 
phagocytic cells may function to generate lipid domains, such as lipid rafts at the 
phagocytic cup, to which CED-1 is recruited. This notion remains highly speculative and 
more studies need to be undertaken to validate this hypothesis. 
CED-7/ABCA1 have also been implicated in intracellular vesicle trafficking. 
Recall, studies in C. elegans have demonstrated a role for CED-7 in intracellular 
endosome trafficking with DYN-1 and RAB7, which respectively facilitate the delivery 
of vesicles to the growing membrane for pseudopod extensions and to phagosomes for 
phagolysosomal maturation (Yu et al., 2006; Yu et al., 2008). Consistent with these 
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events, ABCA1 is known to mediate the transport of lipids from the Golgi to the plasma 
membrane, and was observed to localize to the plasma membrane, the Golgi stacks, and 
endolysosomal vesicles (Hamon et al 2000), cellular compartments which are involved in 
pseudopod extensions and phagolysosomal maturation. These observations support a role 
for CED-7 in intracellular vesicle trafficking for engulfment and possibly degradation of 
the cell corpse. 
In summary, CED-7/ABCA1 may be involved in multiple activities to promote 
cell corpse engulfment, and may be performing different functions in dying cells verses 
phagocytic cells. In dying cells, CED-7 may act to present “eat-me” signals, such as 
PtdSer (Hamon et al., 2000), and bridging molecules, such as TTR-52 (Wang et al., 2010; 
Mapes et al., 2012), to engulfment receptors on phagocytic cells. In phagocytic cells, 
CED-7/ABCA1 may act to promote the formation of lipid rafts to assist CED-1/MEGF10 
clustering at the phagocytic cup (Zhou et al., 2001; Hamon et al., 2006). CED-7 in 
phagocytic cells may also act upstream of CED-10 to promote actin cytoskeletal 
reorganization (Kinchen et al., 2005), upstream of DYN-1 to promote vesicle delivery for 
membrane extensions (Yu et al., 2006; Yu et al., 2008) and/or upstream of RAB-7 to 
promote cell corpse degradation (Yu et al., 2008). Most of the proposed activities of 
CED-7/ABCA1 involve some form of lipid transport, thus it is tempting to speculate that 
the transporter may function to transport lipids. Moreover, CED-7 is broadly expressed in 
C. elegans embryos, (Wu and Horvitz, 1998), suggesting it may be involved in processes 
other than PCD, as supported by the role of ABCA1 in cholesterol efflux (Hamon et al., 
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2000). In summary, it is evident that additional studies are necessary to elucidate the 
precise role and mechanisms of this unique transporter. 
1.3.2 Structure of CED-7/ABCA1 ABC transporters 
ABC transporters represent one of the largest families of transmembrane proteins 
found in all species from bacteria to humans. In humans there are 49 ABC genes arranged 
in seven subfamilies, named ABCA through ABCG (Vasiliou et al., 2009). In mice and 
Drosophila there are 52 and 56 ABC genes, respectively, arranged in eight subfamilies, 
named ABCA through ABCH (Vasiliou et al., 2009; Flybase). These different classes of 
ABC transporters are important in a wide range of physiological processes including 
nutrient uptake, toxin secretion, and drug resistance, and can translocate a diverse variety 
of specific substrates, including sugars, ions, lipids, peptides, proteins, and lipoproteins 
(Rees et al., 2009; Beek et. al. 2014; Wilkens, 2015). 
Crystal structures show that the structural organization of ABC transporters 
consists of four conserved core domains: two cytoplasmic nucleotide-binding domains 
(NBDs) and two transmembrane domains (TMDs) (Figure 1.3). The cytoplasmic NBDs 
contain several highly conserved sequences and motifs involved in the binding and 
hydrolysis of ATP, and serve as the catalytic motor domains utilizing the energy from 
ATP to drive the translocation of substrates. The membrane-spanning TMDs contain 
substrate-specific-binding sites and provide the translocation pathway for substrates 
across the membrane as they undergo conformational changes. These four conserved core 
domains, more importantly the conserved amino acid sequences and structural motifs in 
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the NBDs, are characteristic of all ABC transporters across all prokaryotic and eukaryotic 
organisms (Rees et al., 2009; Vasiliou et al., 2009; ter Beek et. al., 2014; Wilkens, 2015). 
The catalytic NBDs of ABC transporters possess several loops and motifs that are 
highly conserved in primary sequence, order, and spatial distribution, across all ABC 
transporters. Most of these loops and motifs are similar to those found in other ATP-
binding proteins, with the exception of the ‘ABC signature motif’, which is unique to 
ABC transporters. In sequential order, these loops and motifs include an ‘A-loop’ 
containing an aromatic residue, a ‘Walker A motif’ (GxxGxGKS/T where x is any amino 
acid), a ‘Q-loop’ containing a glutamine (Q) residue, an ‘ABC signature motif’ 
(L/YSGGQ/M),  a ‘Walker B motif’ (φφφφDE where φ is a hydrophobic residue), a ‘D-
loop’ containing an aspartate (D) residue, and an ‘H-loop’ containing a histidine (H) 
residue (Figure 1.3). These highly conserved loops and motifs are essential for ATP 
binding and hydrolysis. Mutations in any of these conserved regions result in proteins 
defective in ATP binding and hydrolysis, and substrate transport. These regions are 
presumed to also be involved in coupling ATP hydrolysis to conformational changes in 
the TMDs during substrate translocation (Rees et al., 2009; ter Beek et. al., 2014; 
Wilkens, 2015).  
Contrastingly, the TMDs of ABC transporters lack homology in primary sequence 
and vary in structure and organization. Each TMD can have 6 to 10 α-helical structures, 
though most exporters have 6, for a total of 12 to 20 transmembrane segments in a 
complete ABC transporter. The TMDs of each transporter contain their respective 
substrate-binding sites, thus they can vary based on the chemical nature of their substrate, 
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for example a polar amino acid versus an uncharged sugar. In most cases, the two TMDs 
are identical or very similar in structure, however in some cases, the two TMDs can differ 
structurally and also functionally (Rees et al., 2009; ter Beek et. al., 2014; Wilkens, 
2015).  
Although structural and biochemical data have suggested common mechanistic 
features, such as ATP binding and hydrolysis, the transport mechanisms of ABC 
transporters have not been fully elucidated. The mechanism by which ATP binding and 
hydrolysis occurs and the conformational changes that are induced remains poorly 
understood. This is complicated by the variety of data between ABC transporters (Rees et 
al., 2009; ter Beek et. al., 2014; Wilkens, 2015). This variety is reflected in differences 
observed between the NBDs of ABCA1 and CED-7. In mammals, a KM substitution 
preventing ATP binding and hydrolysis at either or both NBDs, leads to a complete loss-
of-function in ABCA1 (Hamon et al., 2000). Interestingly, in C. elegans, the two NBDs 
seem to have different hierarchal roles. While a KR substitution in the first NBD 
results in engulfment defects, the same mutation in the second NBD produced a limited 
effect (Wu and Horvitz, 1998). Such hierarchal orders of NBDs are not uncommon in 
ABC transporters and suggest that the two NBDs may have distinct roles in controlling 
the transport activity (ter Beek et. al., 2014; Wilkens, 2015). In these cases, the first NBD 
seems to control channel opening, whereas the second NBD seems to control channel 
closing (Wu and Horvitz, 1998).  
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1.3.3 Putative Drosophila melanogaster homologs of ced-7/ABCA1 
The Drosophila genome carries 56 ABC genes, of which 10 encode members of 
the ABCA family (Table 1.2) (Flybase). In the Drosophila ovary, a well-established in 
vivo model for the study of PCD (Jenkins et al., 2013), only 2 of the ABCA encoding 
genes are expressed at appreciable levels, namely CG31731 and CG1718.  
CG1718 has been proposed as the Drosophila homolog of ABCA1 for its role in lipid 
and cholesterol homeostasis. Specifically, the expression of CG1718 was observed to be 
sensitive to dietary lipid and cholesterol concentrations, as larvae reared on a lipid-
depleted medium compared to a standard medium exhibited lower levels of CG1718 
expression, and larvae reared on mediums containing increasingly higher cholesterol 
concentrations exhibited increasingly higher levels of CG1718 expression (Bujold et al., 
2010). These observations are consistent with the idea that under conditions of low lipid 
or cholesterol concentrations, genes that increase their efflux should be turned off. From 
these studies, CG1718 has been speculated to act as the functional homolog of ABCA1 in 
lipid and cholesterol efflux. 
Recent studies in Wolbachia-infected Drosophila cell cultures have also 
supported a role for CG1718 in lipid metabolism. The repression of CG1718 in host cells 
was observed to have a negative effect on Wolbachia infection rates and reduce 
Wolbachia titer (White et al., 2017). The authors speculate that because Wolbachia lack 
essential fatty acid metabolic pathways and are enclosed in a host-derived outer 
membrane, they likely rely on their host’s lipid metabolism for replication. This 
hypothesis is consistent with the requirement for host-derived lipids during replication in 
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other endosymbionts (Paredes et al., 2016). Therefore, CG1718 may act to provide lipids 
to form the Wolbachia outer membrane. 
Currently, there are no reports of a role for CG1718 in PCD. Studies in the 
Drosophila brain did not find a role for CG1718 during axon debris or neuronal-corpse 
clearance (Ziegenfuss, 2012).  While it may be premature to rule out CG1718 as a 
putative homolog of CED-7, its non-requirement in this well-established model of PCD 
that is regulated by the conserved engulfment machinery suggests that other Drosophila 
ABC genes should also be examined. 
Thus far, CG31731, has remained completely uncharacterized, except for a screen 
in which CG31731 was found to be downregulated in the salivary glands of E93 mutants. 
In E93 mutants, the salivary glands fail to undergo developmental PCD (Dutta, 2008), 
suggesting that CG31731 may be involved in promoting salivary gland PCD. Consistent 
with this hypothesis, CG31731 is expressed at very high levels in the salivary gland 
(Flybase). To our knowledge, there have been no follow-up studies to investigate this 
putative role for CG31731.  
Genome-wide analyses of ABC genes in other species, including Daphnia pulex 
(Sturm et al., 2009), Tetranychus urticae (Dermauw et al., 2013), and Bombyx mori (Li et 
al., 2015), have provided several phylogenetic analyses of ABCA encoding genes in C. 
elegans, Drosophila, and humans.  Some of these phylogenetic trees present a closer 
evolutionary relationship between CG31731, compared to CG1718, and ced-7/ABCA1 
(Figure 1.4) (Sturm et al., 2009; Dermauw et al., 2013; Dermauw and Van Leeuwen, 
2014; Li et al., 2015). Considering its putative role in PCD of the salivary gland (Dutta, 
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2008), CG31731 may possess a more similar function to ced-7/ABCA1 in engulfment. 
The lack of concrete evidence necessitates more research to determine whether CG31731 
may act as the functional equivalent of ced-7/ABCA1 during PCD. 
1.4 The Drosophila melanogaster ovary as a model system 
For over a century, Drosophila have been extensively used as a model organism 
for genetic studies. Drosophila possess many characteristics that make them practical for 
laboratory research, including their short life cycle and a fast generation time, they are 
cheap and simple to maintain, and there is a wealth of information and genetic tools 
available for studies in Drosophila. A remarkable amount is known about their biology 
and their genome, which was completely sequenced in 2000. Moreover, the plethora of 
genetic tools has made it relatively straightforward to create transgenic mutants that 
harbor null mutations or tissue-specific gene knockouts, knockdowns, or over-expression, 
to study the function of a gene. While Drosophila only have four chromosome pairs that 
make up a relatively small genome, most of their genes are highly conserved with 
humans. In fact, many of the disease-causing genes in humans are also present in 
Drosophila (Elliott and Ravichandran, 2010; Fuchs and Steller, 2011). Thus, specific 
genes can be easily mutated for biomedical studies of human diseases and without the 
ethical issues of research involving human subjects.   
The Drosophila ovary provides an excellent in vivo model system to study 
engulfment. It is the largest organ in the adult Drosophila (Bastock and St Johnston, 
2008), such that it can be easily dissected, processed, and visualized under the 
microscope for analysis. Importantly, the ovary presents several PCD events including 
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developmental PCD during late oogenesis and starvation-induced PCD during mid-
oogenesis, which exhibit features of apoptosis, necrosis, autophagy, and phagoptosis 
(Jenkins et al., 2013; Timmons et al., 2016). During both PCD events, 15 easily 
visualized nurse cells are normally engulfed and cleared. Since the system is closed to 
circulating macrophages, engulfment is accomplished by neighboring epithelial cells, 
which sufficiently act as non-professional phagocytes (Jenkins et al., 2013). Therefore, 
the ovary relatively easily allows for the in vivo study of engulfment by non-professional 
phagocytes in several different PCD modalities. Additionally, the ovary is not essential 
for survival and thus can be extensively manipulated for genetic studies.  
1.4.1 Oogenesis in the Drosophila melanogaster ovary 
  The female Drosophila carries two ovaries that continuously produce eggs. Each 
ovary is comprised of a bundle of 15-20 ovarioles, which are sheaths containing 
progressively developing egg chambers (Figure 1.5). At the anterior tip of each ovariole, 
a germarium contains germline and somatic stem cells from which egg chambers are 
continuously produced. Egg chambers develop from the germarium towards the posterior 
end through 14 stages in oogenesis (Bastock and St Johnston, 2008; Wu et al., 2008; 
Jenkins et al., 2013). The entire process of oogenesis takes approximately one week from 
the budding of the egg chamber in stage 1 to the maturation into an egg in stage 14 
(Bastock and St Johnston, 2008). At the end of oogenesis, the mature egg passes through 
the oviducts into the uterus, where they can be fertilized (Jenkins et al., 2013). 
  Each egg chamber contains 16 interconnected germline-derived cells surrounded 
by a layer of several hundred somatically-derived follicle cells. In the germarium, 
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germline stem cells produce cystoblasts, each of which undergo four incomplete mitotic 
divisions to form a syncytium of 16 cells interconnected by cytoplasmic ring canals. At 
around stage 2, one of the germline-derived cells differentiates into the oocyte, while the 
remaining 15 become polyploid nurse cells (NCs) (Bastock and St Johnston, 2008; Wu et 
al., 2008; Jenkins et al., 2013).  From stage 2 to 10, the nurse cells provide nutrients, 
proteins, mRNAs, and organelles through the ring canals to the developing oocyte. Then 
at stages 10 and 11, the nurse cells dump their remaining cytoplasmic contents into the 
oocyte in a process known as “dumping”, allowing the oocyte to grow and fill the entire 
egg chamber (Bastock and St Johnston, 2008; Jenkins et al., 2013). Finally, in stages 12 
through 14, the follicle cells facilitate the removal of the remaining nurse cell debris, 
leaving only the mature oocyte by stage 14 (Figure 1.6) (Jenkins et al., 2013).  
  Throughout oogenesis, the somatically-derived follicle cells contribute several 
important functions to form the mature egg. Polar cells, one type of specialized follicle 
cells, provide the necessary differentiation signals to establish the fates of other 
specialized follicle cells including the border cells, the columnar follicle cells, and the 
stretched follicle cells. Then after stage 8, the border cells surround the polar cells and 
migrate to the oocyte where the polar cells form the micropyle. At the same time, the 
epithelial follicle cells migrate to the posterior end to deposit the vitelline membrane and 
eggshell over the oocyte, and provide yolk proteins to the maturing oocyte. The 
remaining ~50 follicle cells at the anterior end stretch over the nurse cells and facilitate 
the removal of the nurse cells. Finally in stage 13 and 14, a patch of follicle cells form the 
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dorsal appendages, which provide chorion proteins for the mature egg (Bastock and St 
Johnston, 2008).  
1.4.2 Developmental PCD during late oogenesis 
  During late oogenesis in stages 12–14, the 15 germline-derived nurse cells 
undergo developmental PCD and are cleared by the neighboring somatically-derived 
stretched follicle cells, leaving only the mature oocyte by stage 14 (Figure 1.7). 
Beginning in stage 12 after “dumping”, the remaining nurse cell nuclei are observed to 
become TUNEL- and LysoTracker- positive, indicating events of DNA degradation, and 
acidification, respectively. DNA degradation as observed by TUNEL staining is a 
hallmark of apoptosis. However, additional studies did not observe a role for caspases or 
the major Drosophila IAP genes, reaper, hid, and grim (RHG), and observed a 
requirement for the Drosophila inhibitor of apoptosis (Diap1) protein. Additionally, 
acidification during PCD could indicate a form of autophagic cell death, however ATG 
genes were also not required for these events. These genetic studies indicate that the 
nurse cells do not undergo apoptosis or autophagic cell death.   
  The presence of acidified vesicles was also observed surrounding the nurse cell 
nuclei (Jenkins et al., 2013). Genetic studies of lysosomal trafficking genes demonstrated 
their requirement in the stretched follicle cells for acidification of the nurse cell nuclei. 
Phagocytosis genes including draper and Ced-12 in the stretched follicle cells and follicle 
cells were also required for the acidification and DNA degradation events in the nurse 
cell (Timmons et al., 2016). The genetic requirement for some genes in the follicle cells 
versus the stretched follicle cells suggest that they are synthesized earlier in oogenesis, 
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before stage 9 when the stretched follicle cell fate is established. Their proteins are likely 
present and also required in the stretched follicle cells for PCD of the nurse cells. 
Furthermore, genetic ablation of the stretched follicle cells prevents the death of the nurse 
cells. These observations indicate that the stretched follicle cells promote these nurse cell 
death events, and propose that they “kill” the nurse cells via phagoptosis (Timmons et al., 
2016).  
  In stages 12–14, the phagocytic receptor Draper becomes enriched on the 
stretched follicle cell membrane, where it is required for clearance of the nurse cells 
(Timmons et al., 2016). The genetic knockout or knockdown of phagocytosis genes, 
including draper, Ced-12, and integrins, in the stretched follicle cells and follicle cells 
prevents removal of the nurse cell corpses, resulting in stage 14 egg chambers exhibiting 
persisting nurse cell nuclei (Timmons, 2015; Timmons et al., 2016).  
1.4.3 Starvation-induced PCD during mid-oogenesis 
 Whereas PCD during late oogenesis occurs in the development of every egg, PCD 
during mid-oogenesis occurs in response to developmental abnormalities or physiological 
stress. PCD of the nurse cells in stages 7–9 can be reproducibly induced by protein 
starvation. The process requires active caspases, including death caspase 1 (Dcp-1), and 
ATG genes, suggesting apoptosis and autophagy both contribute to promote PCD during 
mid-oogenesis (Jenkins et al., 2013). Interestingly, enhanced expression of the phagocytic 
receptor, Draper, can induce PCD in mid-oogenesis egg chambers without starvation, 
suggesting a role for induced phagoptosis (Timmons, 2015). 
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 In starvation-induced PCD, egg chambers proceed through 5 morphologically 
distinct phases primarily defined by changes in the nurse cell chromatin (Figure 1.8). 
Phase 0 healthy egg chambers contain 15 nurse cells with dispersed chromatin. In phase 1 
dying egg chambers, the nurse cell chromatin becomes disordered. In phase 2, the 
chromatin in each nurse cell condenses into several small balls and the follicle cells begin 
to enlarge. In phase 3, the chromatin in each nurse cell becomes highly condensed in a 
single large ball as the follicle cells continue to enlarge. In phase 4, the condensed nurse 
cell chromatin becomes fragmented and some of the germline material is engulfed by the 
follicle cells. By phase 5, only a few if any nurse cell nuclear fragments remain as the 
follicle cells have engulfed the germline material, and enlarged inwards to constitute the 
entire egg chamber (Etchegaray et al., 2012).  
 Draper is required in the follicle cells for engulfment of the dying germline-
derived cells. Starting around phase 3, Draper becomes expressed at the follicle cell 
apical membrane, where the phagocytic cup likely forms facing the germline material. 
Draper staining increasingly accumulates at the phagocytic cup and finally peaks at phase 
5. By phase 5, Draper is also detected inside the follicle cells, suggesting that Draper 
becomes internalized during phagosome formation.  In draper null mutants, dying egg 
chambers exhibit significant engulfment defects as follicle cells fail to enlarge and then 
die without clearing the nurse cell remnants and other germline debris (Etchegaray et al., 
2012). Other engulfment receptors also required in the follicle cells for engulfment 
during mid-oogenesis PCD include integrins (Meehan et al., 2016). 
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1.5 Thesis rationale 
Programmed cell death (PCD) is a critical biological process in animal 
development and tissue homeostasis to prevent disease pathogenesis (Jacobson et al., 
1997; Elliott and Ravichandran, 2010; Fuchs and Steller, 2011). Engulfment represents 
the necessary step in PCD for the selective removal of excess, damaged, and potentially 
deleterious cells programmed to die. The process prevents the accumulation of cell 
corpses and secondarily necrotic cells, which have been implicated as important 
contributing factors to disease pathogenesis (Elliot and Ravichandran, 2010; Fuchs and 
Steller, 2011). 
Genetic studies in C. elegans, Drosophila, and mammals have identified two 
evolutionarily conserved signal transduction pathways:  ced-1/-6/-7 and ced-2/-5/-12, that 
act in parallel to promote multiple events for engulfment (Kinchen et al. 2005; Mangahas 
and Zhou, 2005; Fullard et al., 2009). Of these engulfment machinery components, the 
ABC transporter CED-7 is the only protein reported to be required in both the phagocytic 
cell and the dying cell (Wu and Horvitz, 1998). Whether the mammalian ortholog 
ABCA1 is also expressed in dying cells has yet to be determined. The Drosophila 
ortholog of CED-7/ABCA1 has not been identified.  
The Drosophila ovary provides an excellent in vivo model system to study 
engulfment. Egg chambers in the ovary undergo developmental and inducible PCD 
events, which exhibit features of apoptosis, necroptosis, autophagy, and phagoptosis 
(Jenkins et al., 2013; Timmons et al., 2016). Additionally, the ovary is not essential for 
survival and thus can be extensively manipulated for genetic studies (Bastock and St 
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Johnston, 2008). The plethora of genetic tools and wealth of information about 
Drosophila has made it relatively straightforward to create transgenic mutants that harbor 
null mutations or tissue-specific gene knockouts, knockdowns, or over-expression. 
(Elliott and Ravichandran, 2010; Fuchs and Steller, 2011). 
The goal of our research is to elucidate the genetic pathways and molecular 
mechanisms which regulate PCD in the Drosophila ovary, by identifying and 
characterizing the missing components. Since components of the engulfment machinery 
are evolutionarily conserved, in vivo studies in Drosophila can provide invaluable 
information for understanding the mammalian equivalents. The research presented in this 
thesis characterizes the role of the ABC transporter gene, CG31731, in the engulfment of 
nurse cells during PCD events in the Drosophila ovary, and proposes that CG31731 is the 
Drosophila homolog of ced-7/ABCA1. 
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Table 1.1 The conserved engulfment proteins in C. elegans, Drosophila, and 
mammals. 
 
 
  
C. elegans Drosophila Mammals 
CED-1 Draper MEGF10, JEDI, LRP1 
CED-2 Crk CrkII 
CED-5 Myoblast City DOCK180 
CED-6 Ced-6 GULP 
CED-7 Unknown ABCA1, ABCA7 
CED-10 Rac1 Rac1 
CED-12 Ced-12 ELMO 
DYN-1 Shibire Dynamin 
INA-1 Integrin αPS3/βPS Integrin αvβ5 
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Table 1.2. The ABC transporter encoding genes in Drosophila melanogaster 
Gene Name 
or CG# Genome Location
^ Transporter 
Class 
Ovary 
Expression 
(Microarray)* 
Ovary 
Expression 
(RNA-Seq)** 
CG33173 13E16-13E17 
(X:15,773,171..15,778,703) 
ABCA (no data) low 
CG1819 19F1-19F1 
(X:21,123,634..21,140,951) 
ABCA none low 
CG1494  19F3-19F3 
(X:21,285,301..21,292,458) 
ABCA none none 
CG1718 19F3-19F3 
(X:21,292,308..21,306,665) 
ABCA moderate moderate 
CG1801 19F3-19F4 
(X:21,307,586..21,317,522) 
ABCA none none 
CG31731 34D1-34D1 
(2L:13,784,084..13,790,562) 
ABCA moderate moderate 
CG8908 56F11-56F11 
(2R:20,264,920..20,270,994) 
ABCA none none 
CG6052 74F3-74F3 
(3L:17,723,718..17,729,244) 
ABCA none none 
CG32186 75A2-75A2 
(3L:17,792,088..17,797,594) 
ABCA (no data) none 
CG31213  92C1-92C1 
(3R:19,972,898..19,979,569) 
ABCA none none 
CG3156 1B5-1B5 
(X:487,878..490,725) 
ABCB moderate moderate 
CG1824 11B2-11B2 
(X:12,592,555..12,595,624) 
ABCB moderate low 
Mdr49 49E1-49E4 
(2R:12,940,323..12,946,347) 
ABCB none none 
Mdr50 50E6-50E6 
(2R:14,246,966..14,252,597) 
ABCB none none 
ABCB7 62A8-62A9 
(3L:1,618,414..1,623,413) 
ABCB moderate moderate 
CG10226 65A10-65A10 
(3L:6,234,323..6,240,068) 
ABCB none none 
Mdr65 65A10-65A10 
(3L:6,240,500..6,245,746) 
ABCB none none 
Hmt-1 89A6-89A6 
(3R:15,853,868..15,857,470) 
ABCB moderate high 
CG7806 29A3-29A4 
(2L:8,311,399..8,317,011) 
ABCC moderate moderate 
CG7627 29B1-29B1 
(2L:8,355,678..8,362,469) 
ABCC high high 
Sur 31B1-31B1 
(2L:10,182,557..10,199,117) 
ABCC low none 
MRP1 33F3-33F5 
(2L:12,719,045..12,766,546) 
ABCC high moderate 
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CG31792 37B9-37B9 
(2L:18,997,448..19,002,713) 
ABCC none none 
CG31793 37B9-37B9 
(2L:19,003,367..19,008,234) 
ABCC low low 
CG9270 38F6-38F6 
(2L:20,929,456..20,934,113) 
ABCC none none 
L(2)03659 45D1-45D1 
(2R:9,390,165..9,395,281) 
ABCC low none 
CG10505 57D7-57D8 
(2R:21,285,248..21,290,343) 
ABCC none none 
Mrp4 86E11-86E11 
(3R:11,569,250..11,575,937) 
ABCC (no data) low 
CG4562 92B4-92B4 
(3R:19,865,417..19,875,678) 
ABCC low low 
CG5789 96A6-96A7 
(3R:24,536,204..24,543,914) 
ABCC moderate moderate 
CG11897 98F13-98F13 
(3R:29,158,122..29,164,966) 
ABCC very high very high 
CG11898 98F13-98F13 
(3R:29,165,643..29,171,508) 
ABCC none none 
Pmp70 18F1-18F1 
(X:19,750,770..19,759,280) 
ABCD moderate moderate 
CG2316 102A6-102A6 
(4:184,076..193,829) 
ABCD high moderate 
pix (pixie) 66E6-66E6 
(3L:8,972,056..8,974,765) 
ABCE high high 
CG1703 10D1-10D1 
(X:11,611,927..11,615,128) 
ABCF high high 
CG9281 13E8-13E8 
(X:15,705,806..15,710,539) 
ABCF moderate very high 
CG9330 76B8-76B8 
(3L:19,586,253..19,589,111) 
ABCF moderate high 
w (white) 3B6-3B6 
(X:2,790,599..2,796,466) 
ABCG none low 
CG4822 21B2-21B2 
(2L:116,970..121,754) 
ABCG low none 
CG3164 21B2-21B2 
(2L:122,624..130,791) 
ABCG moderate moderate 
CG17646 22B1-22B2 
(2L:1,732,524..1,750,612) 
ABCG (no data) low 
CG31689 23A3-23A3 
(2L:2,725,674..2,739,830) 
ABCG moderate moderate 
CG9664 23E1-23E1 
(2L:3,291,245..3,294,706) 
ABCG none none 
CG9663 23E1-23E3 
(2L:3,294,926..3,303,130) 
ABCG low low 
E23 23E4-23E5 
(2L:3,334,875..3,354,829) 
ABCG high high 
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Atet 24E1-24E1 
(2L:4,333,913..4,345,776) 
ABCG low low 
CG5853 30F1-30F1 
(2L:9,940,773..9,947,648) 
ABCG low low 
bw (brown) 59E2-59E3 
(2R:23,527,805..23,538,499) 
ABCG low none 
CG32091 68D1-68D1 
(3L:11,631,392..11,642,902) 
ABCG low low 
st (scarlet) 73A3-73A3 
(3L:16,497,651..16,500,460) 
ABCG none none 
CG31121 96B2-96B4 
(3R:24,881,466..24,894,605) 
ABCG (no data) none 
CG11069 96B4-96B4 
(3R:24,894,742..24,897,613) 
ABCG (no data) none 
CG11147 25F4-25F4 
(2L:5,733,675..5,741,244) 
ABCH low low 
CG33970 97A8-97A10 
(3R:26,318,355..26,362,588) 
ABCH low low 
CG9990 98E1-98E2 
(3R:28,675,041..28,695,939) 
ABCH low low 
^Top indicates band position and bottom indicates chromosome and sequence location. 
*Expression levels: none (0-9.999), low (10-99.999), moderate (100-499.999), high (500-
999.999), very high (>999.999). (Data from FlyAtlas Anatomy Microarray, Flybase). 
**Expression levels: none (0-0), low  (1-10), moderate (11-50), high (51-100), very high (101-
1000) (Data from modENCODE Anatomy RNA-Seq, Flybase). 
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Figure 1.1 The general process of engulfment  
 
 
The engulfment process can be described as a succession of 3 steps: (1) “find-me” signals 
secreted by the dying cell recruit the phagocyte to the dying cell, where (2) the phagocyte 
recognizes “eat-me” signals presented by the dying cell, and through a cascade of 
signaling events  (3) the phagocyte internalizes the cell corpse. (Figure modified from 
Ravichandran, 2010)  
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Figure 1.2 The engulfment signaling pathway identified in C. elegans 
 
 
In C. elegans, two distinct parallel but partially redundant signal transduction pathways 
facilitate pseudopod extensions during engulfment.  The CED-1/-6/-7 and CED-2/-5/-12 
pathways converge on CED-10 to promote cytoskeletal rearrangements. The CED-1/-6/-7 
pathway also acts on Dynamin to promote vesicle delivery to the membrane. CED-1 
recognizes “eat-me” signals via the bridging molecule TTR-52, and integrins and other 
ligand receptors have been identified upstream of the CED-2/-5/-12 pathway.  
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Figure 1.3 The general structure of ABC transporters 
 
 
 
ABC transporters comprise of two transmembrane domains (TMD1 and TMD2) and two 
cytoplasmic nucleotide-binding domains (NBD1 and NBD2). In most ABC transporters, 
each TMD consists of 6 transmembrane α-helices (cylinders) for a total of 12 
transmembrane segments in a complete transporter. In all ABC transporters, the NBDs 
contain several highly conserved amino acid sequences involved in the binding and 
hydrolysis of ATP. (Figure modified from Dermauw and Van Leeuwen, 2014) 
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Figure 1.4 Phylogeny tree of ABCA proteins in C. elegans, Drosophila, and humans 
 
The predicted full-length amino acid sequences of ABCA proteins in C. elegans (Ce, 
purple), D. melanogaster (Dm, red), and humans (h, green) were aligned using MUSCLE 
and subjected to a maximum likelihood analysis using Treefinder. Numbers at each 
branch point represent the bootstrap values from 1000 replicates. Scale bar represents a 
0.5 amino acid substitution per site. (Modified from Dermauw et al., 2013)  
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Figure 1.5 The Drosophila ovary and female reproductive structures 
A         B 
 
 
(A)  An illustration of the Drosophila female reproductive system. Each female carries 
two ovaries comprised of a bundle of ovarioles, sheaths containing a germarium and 
progressively developing egg chambers. Egg chambers are produced from the germarium 
at the anterior tip and develop towards the posterior tip until they mature into an egg. 
Mature eggs pass through the oviduct into the uterus where they can be fertilized. (Figure 
modified from Flybase) 
(B)  Two dissected ovaries from the female Drosophila. An ovariole (arrow) is separated 
from the bundle. (Figure from Jenkins et al., 2013) 
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Figure 1.6 The progression of oogenesis 
 
 
 
A schematic of progressively developing egg chambers in an ovariole. Egg chambers are 
produced from the germarium and contain a single oocyte and 15 nurse cells surrounded 
by a layer of follicle cells. After stage 8, a series of migration and differentiation events 
occur to establish the stretched follicle cells, which stretch to surround the nurse cells. 
Between stages 10 and 12, “dumping” of the nurse cell cytoplasmic contents occur. Then 
from stage 12 to 14, the nurse cells undergo developmental PCD and are removed. By 
stage 14, only the mature oocyte which has filled the entire egg chamber remains, and the 
dorsal appendages have fully formed. Protein-starvation in the Drosophila diet can 
induce PCD in stage 7 to 9 mid-oogenesis egg chambers. (Figure kindly provided by Alla 
Yalonetskaya) 
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Figure 1.7 Developmental PCD during late oogenesis 
 
 
 
Egg chambers in the late-stages of oogenesis stained with DAPI (blue) to label DNA. In 
the stage 10 egg chamber, the nurse cells are surrounded by stretched follicle cells and 
still contain their cytoplasm, and the nurse cell nuclei appear dispersed. In the stage 12 
egg chamber, the nurse cells have dumped their cytoplasmic contents into the oocyte and 
the nurse cell nuclei appear condensed. In the stage 13 egg chamber, most of the nurse 
cells have been cleared and only 2 highly condensed nurse cell nuclei remain. 
Additionally, the dorsal appendages begin to form. In the stage 14 egg chamber, all of the 
nurse cells have been cleared, leaving only the mature oocyte. (Images acquired by Alla 
Yalonetskaya) 
  
 
 
46 
 
   
 
Figure 1.8 Starvation-induced PCD during mid-oogenesis 
 
  
 
Healthy and dying egg chambers in mid-oogenesis stained with DAPI (blue) to label 
DNA, and Dlg (magenta) to label follicle cell membrane. Egg chambers express a 
germline-specific GFP gene trap, G89 (green). In the phase 0 healthy egg chamber, the 
nurse cell chromatin is dispersed. In the phase 1 dying egg chamber, the nurse cell 
chromatin becomes disordered (arrow). In the phase 2 dying egg chamber, the chromatin 
in each nurse cell condenses into several small balls (arrow) and the follicle cells begin to 
enlarge (arrowhead). In the phase 3 dying egg chamber, the chromatin in each nurse cell 
becomes highly condensed in a single large ball (arrow) as the follicle cells continue to 
enlarge (arrowhead). In the phase 4 dying egg chamber, the condensed nurse cell 
chromatin becomes fragmented (arrow) and germline material becomes present inside the 
follicle cells (arrowhead). In the phase 5 dying egg chamber, only a few nurse cell 
fragments remain as the follicle cells have enlarged inwards to constitute the entire egg 
chamber (arrowhead). (Figure from Etchegaray et al., 2012)  
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2 CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Drosophila stocks and husbandry 
All stocks (Table 2.1) were obtained from Harvard Transgenic RNAi Project 
(TRiP), Bloomington Drosophila Stock Center (BDSC), or Vienna Drosophila Resource 
Center (VDRC), with the exception of draperΔ5 strains (Freeman et al., 2003) provided 
by Estee Kurant, and draper dsRNA (draperRNAi) strains (MacDonald et al., 2006) 
provided by Marc Freeman. For all experiments, stocks and crosses were reared on 
standard cornmeal molasses yeast medium at 25ºC.  
2.2 Tissue-specific drivers, knockdowns and over-expression 
All tissue-specific RNAi knockdown and over-expression lines were generated 
using the GAL4/UAS binary system (Figure 2.1). In this binary system, the GAL4 yeast 
transcription factor recognizes and binds to upstream activation sequences/UAS sites. For 
all our experiments, expression of GAL4 was placed under control of an endogenous 
tissue-specific enhancer, specifically GR1 in the all follicle cells after stage 3 including 
the stretched follicle cells (Figure 2.2), PG150 only in the specialized stretched follicle 
cells after stage 10, and nanos in the nurse cells. The regulated expression of GAL4 under 
these tissue-specific drivers allowed for the spatiotemporal expression of a target 
transgene inserted downstream of a UAS site. For most of our experiments, GR1-GAL4 
was used to drive the expression of RNAi constructs specifically in the follicle cells. 
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2.3 Preparation of ovaries 
Adult males and females were transferred to a vial containing fresh medium and a 
teaspoon of yeast paste, and conditioned for approximately 2 days. To induce death in 
mid-stage egg chambers, adults were also transferred to apple juice agar vials and starved 
of nutrients for the last 16-20 hour period prior to dissections. 
2.4 Ovary dissection and fixation 
Adults were anesthetized on a CO2 pad and females were sorted from males. 
Subsequently, using forceps each female was submerged in a glass well containing 
Grace’s Insect Media (Fisher) and their reproductive structures were gently pulled out 
from the posterior tip.  Whole ovaries were separated from the other organs and 
transferred to a clean well containing Grace’s media and then to a 0.5 mL Eppendorf tube 
containing fix solution. In order to minimize tissue degradation, dissections were 
performed in <20 minutes and then immediately fixed in a Grace’s Fix containing 300μL 
Grace’s media + 200μL heptane + 100μL <1 week old 16% paraformaldehyde (Electron 
Microscopy Sciences) for 20 minutes while rotating at room temperature. 
2.5 DAPI staining 
DAPI (4',6-diamidino-2-phenylindole) is a DNA-specific stain that emits blue 
fluorescence. Post-fixation, ovaries were quickly rinsed 2 times, and then washed 3 times 
for 20 minutes each with 1X Phosphate Buffered Saline + 0.1% Triton-X (PBT) while 
rotating at room temperature. If desired, ovaries were quickly rinsed in 1X PBS prior to 
adding 1-2 drops of Vectashield Mounting Media with DAPI (Vector Laboratories). 
Ovaries were stored in DAPI at least overnight at 4ºC, until mounted. 
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2.6 Antibody staining 
Standard antibody staining methods were used. Post-fixation, ovaries were 
quickly rinsed 2 times, washed 3 times for 20 minutes each with PBT, and then blocked 
for 1 hour in PBT + 0.5% BSA +5% NGS (PBNG), all while rotating at room 
temperature. Ovaries were then incubated in primary antibodies (Table 2.2) diluted in 
PBNG while rotating overnight at 4ºC. The next day, ovaries were similarly rinsed 2 
times and then washed 4 times for 30 minutes each with PBT, before incubated in 
secondary antibodies (Table 2.2) diluted in PBNG for 1 hour in the dark, all while 
rotating at room temperature. For all subsequent steps, ovaries were protected from light 
using aluminum foil. Following secondary antibody, ovaries were again washed 4 times 
for 30 minutes each with PBT, then quickly rinsed with 1X PBS and stored in 1-2 drops 
of DAPI at least overnight at 4ºC, until mounted. 
2.7 LysoTracker staining 
Immediately following dissection, ovaries were incubated in LysoTracker Red 
DND-99 (Invitrogen) diluted 1:50 in 1X PBS for 3 minutes on the shaker at room 
temperature. Ovaries were then quickly rinsed, washed 3 times for 5 minutes each with 
1X  PBS, fixed in Grace’s Fix for 20 minutes, washed 3 times for 20 minutes each with 
PBT, all while rotating at room temperature, prior to being stored in 1-2 drops of DAPI at 
least overnight at 4ºC, until mounted. 
2.8 TUNEL staining 
TUNEL (terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end 
labeling) is a technique used to detect the 3’-OH ends of DNA fragments. Post-fixation, 
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brains were washed 3 times for 10 minutes each with PBT, then once for 15 minutes with 
1X PBS + 0.2% Triton X-100, while rotating at room temperature. Brains were then 
washed for 10 minutes in equilibration buffer prior to incubated in 45μL equilibration 
buffer + 5μL nucleotide mix + 1μL TdT enzyme for 3 hours at 37ºC in the dark. To stop 
the reaction, 300μL 2X SSC was added to the sample for 1 minute, the brains were 
washed for 15 minutes in 300μL 2X SSC while rotating at room temperature. Finally, 
brains were washed 3 times for 10 minutes each with PBT and then stored in 1-2 drops of 
DAPI at least overnight at 4ºC, until mounted. 
2.9 Mounting 
Using a glass Pasteur pipette, ovaries in DAPI were transferred onto a glass slide 
and teased apart using Tungsten needles (Carolina Biologicals). A cover slip was then 
placed over the slide and sealed with nail polish. Slides were stored at 4ºC and taken out 
only for imaging. 
2.10 Microscopy and imaging 
Egg chambers were viewed using the Olympus BX60 fluorescence microscope, 
and images were captured using the Olympus Cell Sense Entry software. For confocal 
imaging, egg chambers were viewed using the Olympus FluoView FV10i microscope, 
and images captured using the associated program. Confocal images were processed in 
ImageJ and all figures were put together in Microsoft PowerPoint. 
2.11 Quantifications 
  The number of persisting nurse cell nuclei (PN) in each stage 14 egg chamber was 
quantified. Each stage 14 egg chamber was then grouped into bins of 0 PN, 1-3 PN, 4-6 
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PN, 7-9 PN, 10-12 PN, 13-15 PN, and each bin was presented as a percentage of all stage 
14 egg chambers quantified per genotype. Alternatively, the average number of PN in a 
stage 14 egg chamber from each genotype was presented. “n” represents the total number 
of stage 14 egg chambers quantified. 
  The number of late-stage egg chambers exhibiting LysoTracker positive nurse 
cells versus no LysoTracker staining was quantified. Egg chambers were staged as stage 
11 if they were still completing dumping, stage 12 if they had completed dumping, stage 
13 if the dorsal appendage had started to form, and stage 14 if the dorsal appendage had 
fully extended and thickened. The data was presented in a graph showing the percentage 
of egg chambers exhibiting LysoTracker positive nurse cells from each stage 11, 12, 13, 
and 14. 
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Table 2.1 Stocks 
Stock # Associated Alleles Stock Description Source 
 w1118 w[1118]  
 GAL4, G00089 GR1-GAL4,-G00089/TM6B   
 GAL4 PG150-GAL4 
Ellen 
LeMosy 
 GAL4 nanos-GAL4  
 GFP UAS-GFP  
27383 CG31731Δ 
w[1118]; Df(2L)BSC812, 
P+PBac{w[+mC]=XP3.WH3}BSC812/SM6a 
BDSC 
18531 CG31731PBac w[1118]; PBac{w[+mC]=WH}CG31731[f02254] BDSC 
59537 CG31731Mi{MIC} 
y[1] w[*]; 
Mi{y[+mDint2]=MIC}CG31731[MI14571]/SM6a BDSC 
22597 CG31731P{EPgy2} 
y[1] w[67c23];P{w[+mC] 
y[+mDint2]=EPgy2}CG31731[EY22955] BDSC 
v11082 CG31731RNAi-GD1133 w[1118] P{GD1133}v11082 VDRC 
v107135 CG31731RNAi-KK104197 P{KK104197}VIE-260B VDRC 
65080 CG31731RNAi-HMC06027 
y[1] sc[*] v[1]; 
P{y[+t7.7] v[+t1.8]=TRiP.HMC06027}attP40 
TRiP 
38353 CG1718RNAi-HMS01821 y[1] v[1]; 
P{y[+t7.7] v[+t1.8]=TRiP.HMS01821}attP40 
TRiP 
38329 CG1718RNAi-HMS01796 
y[1] sc[*] v[1]; 
P{y[+t7.7] v[+t1.8]=TRiP.HMS01796}attP2 TRiP 
v44449 CG1718RNAi-GD3708(49) w[1118]; P{GD3708}v44449 VDRC 
v44451 CG1718RNAi-GD3708(51) w[1118]; P{GD3708}v44451 VDRC 
v105608 CG1718RNAi-KK100452 P{KK100452}VIE-260B VDRC 
58885 CG1718miR-1007-KO w[*] TI{TI}mir-1007[KO] CG1718[mir-1007-KO] BDSC 
 draper-/- draperΔ5 
Estee 
Kurant 
67034 draperRNAi y[1] w[*]; P{w[+mC]=UAS-drpr.dsRNA}2/CyO 
Marc 
Freeman 
28556 Ced-12RNAi 
y[1] v[1]; 
P{y[+t7.7] v[+t1.8]=TRiP.HM05042}attP2 
TRiP 
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Table 2.2 Antibodies 
Antibody Host Dilution Source 
anti-Draper Rabbit 1:200 Marc Freeman 
anti-Discs Large (Dlg) Mouse 1:100 Developmental Studies Hybridoma Bank 
anti-cleaved Dcp-1 Rabbit 1:100 Cell Signaling Technology 
anti-mouse Cy3 Goat 1:100 Jackson ImmunoResearch 
anti-rabbit Cy3 Goat 1:100 Jackson ImmunoResearch 
anti-rabbit AlexaFluor 647 Goat 1:100 Jackson ImmunoResearch 
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Figure 2.1 The GAL4/UAS binary system  
 
 
In the GAL4-UAS binary system, one parent carries the GAL4 yeast transcription factor 
downstream of an endogenous tissue-specific enhancer, while the other parent caries the 
target transgene downstream of a UAS site. In their resulting offspring, GAL4 can 
recognize and bind the UAS site to induce tissue-specific expression of the target 
transgene. (Figure modified from Muqit and Feany, 2002)  
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 Figure 2.2 GR1-GAL4 expression in egg chambers 
A      B         C 
 
Images show egg chambers expressing endogenous GFP specifically in the follicle cells 
(GR1-GAL4/UAS-GFP). GR1-mediated GFP expression is observed beginning in stage 3 
egg chambers (arrowheads), specifically in the (A) epithelial follicle cells including those 
in (B) mid-stage dying egg chambers and in the (C) specialized stretched follicle cells. 
(Figure from Timmons, 2015)  
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3 CHAPTER 3: RESULTS AND DISCUSSION 
 
3.1 Background 
Programmed cell death (PCD) is a necessary biological process in animal 
development and tissue homeostasis that facilitates the selective removal of excess, 
damaged, and potentially deleterious cells. (Jacobson et al., 1997; Elliott and 
Ravichandran, 2010; Fuchs and Steller, 2011). Cells undergoing PCD are rapidly cleared 
by phagocytes in a multi-step engulfment process involving recognition followed by 
internalization of the dying cell (Figure 1.1) (Fullard et al., 2009; Elliot and 
Ravichandran, 2010). Genetic studies in C. elegans have identified two parallel but 
partially redundant signaling pathways, CED-1/-6-/7 and CED-2/-5/-12, that regulate the 
engulfment process (Figure 1.2) (Kinchen et al., 2005; Mangahas and Zhou, 2005). These 
pathways appear to be conserved in mammals in MEGF10/GULP/ABCA1 and 
Crk/DOCK180/ELMO, and in Drosophila in Draper/Ced-6 and Crk/MBC/Ced-12, 
respectively (Table 1.1) (Mangahas and Zhou, 2005; Fullard et al., 2009). The 
Drosophila homolog for CED-7/ABCA1 has not been identified. To elucidate the precise 
roles and molecular mechanisms of these evolutionarily conserved signaling pathways 
during engulfment, it would be beneficial to identify and characterize all the components 
of the engulfment machinery, especially the Drosophila homolog for CED-7/ABCA1. 
The ced-7/ABCA1 genes encode ABCA transporters (Wu and Horvitz, 1998; 
Luciani and Chimini, 1996). To search for putative ced-7/ABCA1 orthologs, we identified 
56 ABC genes in the Drosophila genome, 10 of which encoded members of the ABCA 
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family, and  only 2 are expressed at appreciable levels in the ovary, CG31731 and 
CG1718 (Table 1.2). CG1718 was previously implicated in lipid and cholesterol 
homeostasis (Bujold et al., 2010; White et al., 2017), suggesting that the protein may act 
as the functional equivalent of ABCA1. However, separate studies did not observe a role 
for CG1718 in axon degeneration (Ziegenfuss, 2012). CG31731 has remained largely 
uncharacterized, although several genome wide phylogenetic analyses of ABCA proteins 
in Drosophila, C. elegans, and humans, have identified a closer evolutionary relationship 
between ced-7/ABCA1 and CG31731 versus CG1718 (Figure 1.4) (Dermauw et al., 2013; 
Dermauw and Van Leeuwen, 2014). The lack of data for either gene implies much more 
research is needed to determine whether they are involved in PCD. 
To identify a potential role for CG31731 or CG1718 in PCD, we analyzed their 
function during developmental and starvation-induced PCD in the Drosophila ovary. 
During the late-stages of oogenesis, 15 germline-derived nurse cells undergo 
developmental PCD and are cleared by neighboring phagocytic follicle cells (Figure 1.7). 
It has been shown that phagocytosis genes including draper and Ced-12, are required in 
the follicle cells for the death and removal of the nurse cells, suggesting that the follicle 
cells directly promote the death of the nurse cell by phagoptosis. Genetically knocking 
down these and other engulfment genes in the follicle cells disrupts clearance of the nurse 
cell remnants, resulting in stage 14 egg chambers that exhibit persisting nurse cells 
(Timmons et al., 2016).  
During mid-oogenesis, the nurse cells can undergo PCD in response to 
physiological stress. Mid-stage egg chambers from adult females starved of protein can 
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exhibit apoptotically and autophagically dying nurse cells (Jenkins et al., 2013). As the 
nurse cells degenerate, the surrounding phagocytic follicle cells synchronously enlarge to 
engulf the germline debris (Figure 1.8). Functional mutations in engulfment genes 
including draper, Ced-12, and αPS3/βPS integrin do not appear to affect the death of the 
nurse cells, however cause defects in their engulfment as follicle cells fail to enlarge 
normally and only minimally uptake the germline debris. Strikingly, these engulfment 
defects are accompanied by premature death and disappearance of the follicle cells by 
phase 5 dying egg chambers, leaving behind unengulfed germline material (Etchegaray et 
al., 2012; Timmons, 2015; Meehan et al., 2015). 
Our observations strongly suggest that CG31731 is required in the follicle cells 
for nurse cell clearance during PCD in both late and mid-oogenesis. We show that 
genetically knocking down CG31731 in the follicle cells results in persisting nurse cells 
in late-stage egg chambers, and engulfment defective follicle cells in mid-stage dying egg 
chambers.  We did not find an independent role for CG1718 in these PCD events, 
although we have some evidence to speculate that CG1718 may provide a compensatory 
mechanism for CG31731. Altogether, our findings suggest that CED-7/ABCA1 plays an 
evolutionarily conserved role during engulfment in Drosophila through CG31731. 
3.2 CG31731 and CG1718 encode ABC transporters similar to ced-7/ABCA1 
A search of protein databases revealed that the predicted amino acid sequences of 
CG31731 and CG1718 encode ABC transporters. Like other ABC transporters, CG31731 
and CG1718 each encode two membrane-spanning TMDs and two cytosolic NBDs with 
predicted ATP-binding and catalytic capability. Each NBD in CG31731 and CG1718 was 
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found to contain an ‘A-loop’ (aromatic), ‘Walker A motif’ (GxxGxGKS/T), ‘Q-loop’ 
(glutamine, Q), ‘ABC signature motif’ (L/YSGGQ/M), ‘Walker B motif’ (φφφφDE), ‘D-
loop’ (aspartate, D), and ‘H-loop’ (histidine, H), in highly conserved sequential and 
spatial organization (Figure 3.2 and Figure 3.3), classifying these proteins as ABC 
transporters. Additional structural analyses of the predicted amino acid sequences 
indicate that each CG31731 TMD contains 6 hydrophobic α-helical segments making a 
12-pass transporter (Figure 3.1A), while each CG1718 TMD contain 7 hydrophobic α-
helical segments making a larger 14-pass transporter (Figure 3.1B). In comparison, both 
CED-7 and ABCA1each contain 15 transmembrane segments (Figure 3.1C-D) 
(UniProt.org).  
Using Basic Local Alignment Search Tool (BLAST) algorithms to compare the 
predicted amino acid sequences of CG31731 and CG1718 with CED-7 and ABCA1, a 
substantial amout of similarity and identity was found throughout their entire length, and 
most notably in the regions of the catalytic NBDs (Figure 3.2 and Figure 3.3). CG31731 
was found to be 20% identical to CED-7 with 577 similar amino acid positions, and 18% 
identitical to ABCA1 with 584 similar amino acid positions. Even more immpresive, 
CG1718 was found to be 25% identical to both CED-7 and ABCA1 with 642 and 562 
similar amino acid positions, respectively. The greater sequence similarity to CED-7 and 
ABCA1 suggests CG1718 is evolutionarily closer to ced-7 and ABCA1 compared to 
CG31731. However, CED-7 and ABCA1 only share 18.5% identity and  635 similar 
amino acid positions, indicating that a higher identity does not necessarily correlate to 
functional homology. 
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Additional homology searches using the Drosophila RNAi Screening Center 
(DRSC) Interative Ortholog Prediction Tool (DIOPT) revealed that CG31731 is the best 
predicted ortholog of ced-7 in Drosophila. CG1718 was also listed as a putative ced-7 
ortholog, although the gene ranked much lower than CG31731 and several other 
predicted Drosophila genes. Unexpectedly, both the human and mouse ABCA1 was not 
predicted as an ortholog of ced-7, though it was for CG31731 and CG1718, albeit very 
low on the list. Nonetheless, ABCA1 has been experimentally shown to be required for 
engulfment in multiple systems, serving as the functional equivalent of ced-7. ABCA7, 
which does not appear on the list, has also been shown to have a role in engulfing glia 
(Jehle et al., 2006). These discrepancies highlight the inadequacy of identifying orthologs 
merely via sequence analyses. To unambiguously determine the ced-7 ortholog in 
Drosophila, it was necessary to study the functional role of putative genes including 
CG31731 and CG1718 in PCD. 
3.3 CG31731 and CG1718 genes and insertions 
The CG31731 gene is located on chromosome 2L, 34D1 on the cytogenetic map, 
and extends from 13,784,084–13,790,562. There are 2 mRNA transcripts associated with 
the gene, CG31731-RC and CG31731-RB (Figure 3.5A).  Structural analyses of the 
predicted amino acid sequence translated from each transcript indicate that CG31731-RC 
merely encodes a truncated protein containing 6 transmembrane segments, while 
CG31731-RB encodes the full 12-pass ABC transporter (Uniprot.org). The CG1718 gene 
is located on chromosome X, 19F3 on the cytogenetic map, and extends from 
21,292,308–21,306,665. There are 3 mRNA transcripts associated with the gene, 
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CG1718-RB, CG1718-RC, and CG1718-RD (Figure 3.6).  Sequence alignment indicated 
that all 3 transcripts encode almost identical polypeptides that form 14-pass ABC 
transporters (UniProt.org).  
A number of genetic tools are readily available to study the in vivo function of 
both genes. There are three alleles of CG31731, each carrying a different transgenic 
transposon:  P{EPgy2}, PBac{WH}, or Mi{MIC} (Figure 3.5A-B). The P{EPgy2} 
construct is inserted after the first 2 nucleotides in the first coding exon, and contains 
GAGA and UAS-binding sites upstream of the promoter (Bellen et al., 2004; Bellen et 
al., 2011). These elements and the inserted orientation of the P{EPgy2} construct allows 
for GAL4-transcriptional regulation of the gene to over-express the gene. The PBac{WH} 
construct is inserted towards the end of the first coding exon, and contains Su(Hw)-
binding sequences, an FRT site, and a UAS-binding site (Bellen et al., 2011). The 
Su(Hw) sequences allow for the binding of Su(Hw) proteins, which serve as molecular 
insulators that alter the local chromatin organization to inactivate the gene. Lastly, the 
Mi{MIC} construct is inserted in the intronic region between the second and third exon, 
and contains a splice acceptor site followed by stop codons in all three reading frames, 
and a downstream EGFP coding sequence followed by a polyadenylation signal (Venken 
et al., 2011). The insertion of the Mi{MIC} construct in an intron allows it to function as 
both a gene trap and a protein trap to prematurely terminate transcription and translation 
of the gene. The resulting protein should in theory only contain a single transmembrane 
segment without any ABC transporter activity. Collectively, these transgenic alleles 
provide the tools to over-express or disrupt CG31731 to study its function.    
 
 
62 
 
   
 
Additionally, there are 3 RNAi lines available from the GD, KK, and HMC RNAi 
libraries, that specifically target the CG31731 mRNA transcripts. Respectively, the 
GD1133 and KK104197 RNAi constructs target exons 13 and 14, and therefore only knock 
down the CG31731-RB transcript encoding the full ABC transporter. The HMC06027 
RNAi construct targets exon 6 and therefore could knock down both the CG31731-RB 
and –RC transcripts (Figure 3.5A). At the time this project began, only the GD and KK 
RNAi lines, which both encode long hairpin RNAs, were available. To optimize our 
study of CG31731 in the germline-derived nurse cells, we requested DRSC/TRiP to 
generate the HMC RNAi line, which expresses short hairpin RNA sequences for effective 
knockdown in the germline. In C. elegans, CED-7 was reported to be required in both the 
phagocytic cells and the dying cells for efficient engulfmen (Wu and Horvitz, 1998). 
Using these RNAi lines and various GAL4 tissue-specific drivers, we can suppress 
CG31731 gene expression only in specific cell types, including in the somatically-derived 
phagocytic follicle cells or the germline-derived dying nurse cells, to identify in which 
cell type it may be functioning. 
Similarly, a number of RNAi constructs are readily available for the study of 
CG1718 (Figure 3.6). There are 2 HMS RNAi lines which express short hairpin RNA 
sequences, and 2 GD and 1 KK RNAi line which express long hairpin RNA sequences, 
for RNAi-mediated CG1718 gene silencing in the germ cells or somatic cells. All the 
RNAi constructs target regions in all 3 mRNA transcripts associated with the CG1718 
gene. Furthermore, there is an additional miR-1007 knockout mutant strain, in which the 
expression of CG1718 was reported to be affected (Chen et al., 2014). The miR-1007 
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gene is nestled in one of the intronic regions of CG1718. A systematic study of 
Drosophila microRNA (miR) functions conveniently generated the CG1718miR-1007-KO/ miR-
1007-KO strain, confirmed via PCR. Quantitative RT-PCR of the CG1718 host gene in 
CG1718miR-1007-KO/ miR-1007-KO mutants showed a reduced expression of CG1718 (Chen et 
al., 2014), suggesting that the miR-1007KO mutation generates a hypomorphic allele of 
CG1718. 
3.4 CG31731 mutants have persisting nurse cell corpses in the ovary 
To determine whether CG31731 or CG1718 can act as a functional equivalent for 
ced-7/ABCA1 during PCD, we analyzed their engulfment function in oogenesis, during 
which 15 germline-derived nurse cells undergo PCD and are cleared. In wild-type 
developing egg chambers, clearance of the 15 nurse cells begin after they complete 
“dumping” of their cytoplasmic contents into the oocyte in stage 12. By stage 14, all the 
nurse cells are cleared leaving only the mature oocyte. To observe any engulfment 
defects, we stained fixed ovaries with DAPI to label DNA from CG31731 mutants and 
looked for the presence of uncleared persisting nurse cell nuclei.  
In several different CG31731 mutant strains, we observed significant engulfment 
defects characterized by the presence of ≥4 persisting nurse cell nuclei in stage 14 egg 
chambers. In ovaries from homozygous CG31731PBac/ PBac or CG31731Mi{MIC}/Mi{MIC}  
mutants, and hemizygotes in trans to a deficiency, CG31731PBac/- or CG31731Mi{MIC}/-, 
most developing egg chambers failed to clear all 15 nurse cells by stage 14 and exhibited 
persisting nurse cell nuclei (Figure 3.7A). Homozygous CG31731PBac/ PBac mutants 
displayed the weakest engulfment defective phenotype with only approximately 34% of 
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the stage 14 egg chambers displaying ≥4 persisting nurse cell nuclei. Interestingly, the 
heterozygous CG31731PBac/Mi{MIC} and hemizygous CG31731PBac/- mutants displayed a 
similar phenotype to the CG31731Mi{MIC}/Mi{MIC} mutants, with approximately 74-80% of 
stage 14 egg chambers displaying ≥4 persisting nurse cell nuclei, and an average of 6 
persisting nuclei per stage 14 egg chamber (Figure 3.7B-C). The weaker phenotype 
observed in the CG31731PBac/ PBac egg chambers relative to the other mutants suggests the 
CG31731PBac allele is a weak hypomorph. The strongest phenotype was observed in 
hemizygous CG31731Mi{MIC}/- mutants, of which approximately 95% displayed ≥4 with 
an average of 8 persisting nurse cell nuclei per stage 14 egg chamber (Figure 3.7B-C). 
The Mi{MIC} insertion provides both a gene trap and a protein trap, which in theory 
should efficiently generate a null allele. However, the more severe persisting phenotype 
in CG31731Mi{MIC}/- mutants with a deficiency allele compared to homozygous 
CG31731Mi{MIC}/Mi{MIC} mutants suggest that the CG31731Mi{MIC} allele only causes a 
partial loss of expression in CG31731, unless other genes affected by the deficiency are 
contributing to the more severe phenotype. Based on only our genetic analyses, the 
CG31731Mi{MIC} allele is not a null but a strong hypomorph. While the expression of the 
CG31731PBac and CG31731Mi{MIC} alleles is not certain, it is evident that the manner by 
which both mutations disrupt the CG31731 gene show that CG31731 plays an important 
role in nurse cell clearance during late oogenesis. 
  The P{EPgy2} construct did not appear to disrupt the CG31731 gene as egg 
chambers from heterozygous and hemizygous CG3173P{EPgy2} mutants did not display 
any significant defects in engulfment or persisting nuclei phenotype (Figure 3.8A-B). 
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This is not surprising since none of the elements in the P{EPgy2} construct provides the 
means to negatively regulate CG31731 gene expression. In theory, the P{EPgy2} insert 
could disrupt the gene since the construct is inserted such that it interrupts the start codon 
(Figure 3.4). However, several other ATG start codons downstream of the insertion, one 
of which starts the second exon (Figure 3.4), would allow normal transcription of 
CG31731. In this case, starting transcription at the second exon is likely inconsequential, 
since the first exon encodes a likely non-essential non-membrane-spanning segment of 
TMD1. Thus, the CG3173P{EPgy2} allele likely encodes a functional CG31731 ABC 
transporter. Enhanced expression of CG31731 with the P{EPgy2} construct specifically 
in the phagocytic stretched follicle cells, the follicle cells, or the dying nurse cells, also 
did not disrupt nurse cell clearance (Figure 3.9A-B). 
  We found that mutants carrying only one copy of a hypomorphic allele or a 
deficiency of CG31731 in trans to a WT allele did not exhibit any notable defects in 
nurse cell clearance (Figure 3.10). Although a few stage 14 egg chambers had persisting 
nurse cell nuclei, in most developing egg chambers all 15 nurse cells were removed by 
stage 14. These findings suggest that CG31731 is not haploinsufficient, and one copy of 
the CG31731 allele is sufficient for its protein function during engulfment. 
3.5 CG31731 is required in the follicle cells for nurse cell clearance during 
developmental PCD 
  Our analyses of the CG31731PBac, CG31731Mi{MIC}, and CG31731- mutants show 
that CG31731 is involved in nurse cell clearance during oogenesis. We next wanted to 
discern in which cell type CG31731 function is required to facilitate removal of the nurse 
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cells. Studies in C. elegans showed that CED-7 is required in both the phagocytic cell and 
the dying cell for efficient engulfment of cell corpses (Wu and Horvitz, 1998), while 
studies in mammals showed that ABCA1 expression in phagocytic cells is sufficient for 
engulfment (Hamon et al., 2000). In the Drosophila ovary, the nurse cells become 
surrounded by the phagocytic stretched follicle cells, which facilitate the engulfment of 
the dying nurse cells. The loss of important engulfment proteins including Draper and 
Ced-12 in the stretched follicle cells and follicle cells have been shown to prevent 
engulfment of the nurse cell corpses (Timmons et al., 2016). To determine in which cell 
type CG31731 acts during engulfment of the nurse cells, we used tissue specific drivers 
to express CG31731 RNAi constructs specifically in the stretched follicle cells, follicle 
cells, or nurse cells. 
  Unexpectedly, the expression of CG31731 RNAi specifically in the stretched 
follicle cells (PG150>CG31731RNAi) did not disrupt clearance of the nurse cells (Figure 
3.11A-B). Most of the stage 14 egg chambers successfully cleared all 15 nurse cells and 
did not have any persisting nurse cell nuclei. We speculated that perhaps CG31731 is 
expressed much earlier in development before the stretched follicle cells specialize from 
the follicle cells. Consistent with this hypothesis, we observed a requirement for 
CG31731 expression in the follicle cells, as CG31731 knockdown specifically in the 
follicle cells (GR1>CG31731RNAi) resulted in stage 14 egg chambers exhibiting persisting 
nurse cell nuclei (Figure 3.12A). Approximately 87% of the stage 14 egg chambers 
expressing the GD1133 RNAi construct and 67% expressing either the KK104197 or 
HMC06027 RNAi construct displayed ≥4 persisting nurse cell nuclei, with an average of 7 
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and 4-5 persisting nuclei respectively (Figure 3.12B-C). In developing egg chambers, the 
stretched follicle cells differentiate from the follicle cells during a series of migration 
events after stage 8. These data indicated that CG31731 is primarily expressed before 
stage 8 in the follicle cells, where it is required for nurse cell clearance. The stretched 
follicle cells likely retain some of its molecular components that were present in the cell 
prior to becoming specialized follicle cells, suggesting that while CG31731 expression is 
not required in the stretched follicle cells, presence of the CG31731 protein is likely 
required in these specialized follicle cells for their phagocytic function.  
  To verify that the CG31731 RNAi constructs specifically knock down CG31731, 
we expressed the CG31731 RNAi constructs in a CG31731P{EPgy2} background, where 
CG31731 expression should be enhanced. The rescue of engulfment defects observed in 
GR1>CG31731RNAi egg chambers with the CG31731P{EPgy2} allele would suggest that the 
RNAi constructs accurately target CG31731. However, we did not observe any reduction 
in persisting nurse cell nuclei, or rescue phenotype in these double mutants. Instead, our 
quantifications indicate a similar phenotype between these double mutants and 
GR1>CG31731RNAi only egg chambers (Figure 3.13). After these experiments, it was 
discovered that the CG31731P{EPgy2} parental stock used generate the F1 double mutants 
was contaminated. While we are not certain that the double mutants weren’t also 
contaminated, at the time the double mutants were generated, they were visually checked 
to carry the correct markers and balancers. Assuming the double mutants were correct, 
we considered the possibility that the GD1133 and KK104197 RNAi constructs may be 
targeting other genes. This is unlikely since both sequences perfectly target several 
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hundred nucleotide sequences in CG31731 transcripts. Moreover, a BLAST search of the 
sequences of both RNAi constructs identified CG31731 as the single on-target hit, 
consistent with the information provided by VDRC. Another possibility is that there is 
not enough GAL4 synthesized to simultaneously drive the expression of both 
CG31731RNAi and CG31731P{EPgy2}, and GAL4 may preferentially bind the UAS 
sequences upstream of the CG31731RNAi rather than CG31731P{EPgy2} transgene. 
Alternatively, the RNAi machinery may be superbly robust and efficiently knock down 
CG31731 mRNA transcripts even when in abundance, effectively silencing CG31731 
gene expression. From our data, it is not clear exactly what is happening at the molecular 
level, but the simultaneous expression of CG31731P{EPgy2} does not appear to rescue the 
engulfment defects in follicle cell specific CG31731RNAi expressing egg chambers. 
  In C. elegans, CED-7 was found to be required in the phagocytic and the dying 
cells for efficient engulfment (Wu and Horvitz, 1998). To determine whether CG31731 
may also act in dying cells in Drosophila, we knocked down CG31731 specifically in the 
nurse cells (nanos>CG31731RNAi), which undergo PCD during oogenesis. Contrarily, we 
did not observe a requirement for CG31731 in the dying nurse cells. Egg chambers 
expressing CG31731RNAi specifically in the nurse cells did not appear to have any 
engulfment defects and were able to clear the nurse cells normally (Figure 3.14A-B). 
While GD and KK RNAi libraries generate long hairpin RNA sequences, which are 
typically ineffective for RNAi-mediated knockdown in the germline, the HMC06027 
encoded short hairpin RNA sequence should competently knockdown CG31731 
expression in the germline-derived nurse cells. The lack of persisting nurse cell corpses in 
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any of these CG31731 RNAi expressing stage 14 egg chambers suggest that unlike CED-
7, CG31731 is not required in the dying cells for their engulfment. 
3.6 CG1718 may act with CG31731 in the follicle cells for nurse cell clearance during 
developmental PCD  
  We also examined the engulfment function of CG1718, another putative CED-7 
homolog, in nurse cell clearance during oogenesis. CG1718 encodes another ABCA 
protein that is expressed in the ovary, and has been proposed as the Drosophila homolog 
of ABCA1 for its activity in lipid and cholesterol homeostasis (Bujold et al., 2010). 
However, studies in neuronal corpses and engulfing glia did not observe a role for 
CG1718 (Ziegenfuss, 2012). To determine whether CG1718 has a role in nurse cell 
clearance, we looked for persisting nurse cell nuclei in CG1718 mutants. 
  Similar to our genetic studies of CG31731, we did not observe a requirement for 
CG1718 in the nurse cells for their removal. Egg chambers expressing CG1718RNAi 
specifically in the nurse cells (nanos>CG1718RNAi) normally cleared all 15 nurse cell 
remnants by stage 14 (Figure 3.15). Intriguingly, while egg chambers expressing one of 
four different CG1718RNAi transgenes specifically in the follicle cells (GR1>CG1718RNAi) 
also appeared to normally clear the dying nurse cells, expression of the HMS01821 RNAi 
construct specifically in the follicle cells resulted in moderate engulfment defects (Figure 
3.16A-B). Quantification of the stage 14 egg chambers expressing CG1718HMS01821  in the 
follicle cells indicated approximately 45% displayed ≥4 and an additional 30% displayed 
1-3 persisting nurse cell nuclei (Figure 3.16B). Unique from the other CG1718 RNAi 
constructs, the HMS01821 RNAi sequence targets the 3 prime untranslated regions 
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(3’UTRs) of the CG1718 transcripts (Figure 3.6). While studies have reported that 
compared to the coding region the 3’UTR is often less accessible, some studies have 
shown that the 3’UTR can provide more effective targets for RNAi-mediated knock 
down of certain genes (Lai et al., 2013). It is tempting to speculate that the other CG1718 
RNAi constructs, which target the coding regions of CG1718, ineffectively knock down 
CG1718, while the HMS01821 RNAi construct effectually does. Another possibility is that 
the HMS01821 RNAi encoded sequence may be targeting another gene. A BLAST search 
of the RNAi sequence on Flybase identified CG1718 as the single on-target hit (E-
value=0.00018). The search also revealed potential off-target hits including the intronic 
region of pointed (E-value=0.17348), the 3’UTR of smooth (E-value=0.17348), the 
coding exon of CG44004 (E-value=0.68550), and the 3’UTR of snx6. Perhaps not by 
coincidence, pointed has been implicated in phagocytosis in S2 cells (Stroschein-
Stevenson et al., 2006) and in follicle cell development (Dobens and Raftery, 2000). 
Therefore the phenotypes observed in egg chambers expressing CG1718HMS01821 in the 
follicle cells may actually be associated with off-target knockdown of pointed. 
Nevertheless, there is still a possibility that the knockdown was on-target and that 
CG1718 may act in the phagocytic follicle cells for removal of the nurse cells during 
oogenesis.  
  Since CG1718 and CG31731 both encode ABC transporters of the ABCA family, 
which share a common function in lipid transport, we wondered whether they could 
provide compensatory roles for each other. We used the GR1-GAL4 driver to express 
both CG1718HMS01821 and CG31731P{EPgy2} specifically in the follicle cells, to 
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simultaneously knock down CG1718 and over-express CG31731. The rescue of 
engulfment defects observed in GR1>CG1718HMS01821 egg chambers with an over-
expression of CG31731 would suggest that CG31731 can compensate for the lack 
CG1718. Our quantifications of these mutants showed that expression of CG31731P{EPgy2} 
did not significantly reduce or rescue the number of persisting nurse cell corpses in 
follicle cell-expressing CG1718HMS01821 egg chambers (Figure 3.17B-C). These data do 
not definitively rule out the potential for compensatory functions between the ABCA 
genes, especially since the over-expression of CG31731 with the P{EPgy2} construct is 
questionable. Additional studies are needed to determine whether CG1718 and CG31731 
can actually compensate for each other during engulfment in the ovary.  
  In CG1718miR-1007-KO/ miR-1007-KO mutants, the expression of CG1718 was reported 
to be reduced (Chen et al., 2014). We also analyzed egg chambers from these mutants 
and did not observe any prominent engulfment defects as most developing egg chambers 
successfully cleared the nurse cells by stage 14 (Figure 3.18A-C). To further explore a 
potential relationship between CG1718 and CG31731, we generated CG1718miR-1007-KO/ 
miR-1007-KO+CG31731PBac/ PBac double mutants carrying homozygous hypomorphic alleles 
of both genes. To our surprise, these double mutants exhibited a much more severe 
persisting nuclei phenotype than either single mutant alone (Figure 3.18A). Interestingly, 
the CG1718miR-1007-KO/ miR-1007-KO+CG31731PBac/ PBac mutants displayed a similar 
engulfment defective phenotype to CG31731PBac/-,  CG31731PBac/Mi{MIC}, and homozygous 
CG31731Mi{MIC}/Mi{MIC} mutants (Figure 3.7A-C), with approximately 83% of egg 
chambers displaying ≥4 persisting nurse cell nuclei, and an average of 6 persisting nuclei 
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per stage 14 egg chamber (3.18B-C). The much more severe phenotype observed in 
CG1718miR-1007-KO/ miR-1007-KO+CG31731PBac/ PBac double mutants indicate a functional 
relationship between the two ABCA transporters, and suggest CG1718 may provide a 
compensatory function for CG31731 during nurse cell clearance in developing egg 
chambers.   
3.7 CG31731 acts in parallel to Ced-12 likely in the same pathway as draper 
  The engulfment mechanism is primarily regulated by two parallel signaling 
pathways, CED-1/-6/-7 and CED-2/-5/-12 (Mangahas and Zhou, 2005; Fullard et al., 
2009). Previous work in our lab has shown that the Draper and Ced-12 pathways act in 
parallel to regulate engulfment of the nurse cells during oogenesis. Double mutants 
expressing draperRNAi+Ced-12RNAi in the follicle cells exhibit a significantly more severe 
persisting nurse cell phenotype compared to either single mutant alone (Timmons et al., 
2016). In C. elegans and mammals, CED-7/ABCA1 acts in the same pathway as CED-
1/MEGF10 parallel to CED-12/ELMO. The similarities we have observed between 
CG31731 and CED-7 suggest CG31731 may act in the same pathway as Draper and 
parallel to Ced-12. To ascertain which pathway CG31731 is involved in during 
engulfment, we generated CG31731+draper and CG31731+Ced-12 double mutants and 
analyzed the severity of their engulfment defects in nurse cell clearance.  
  We showed that homozygous CG31731Mi{MIC}/Mi{MIC} mutants exhibit a strong 
engulfment defect in developing egg chambers, of which approximately 74% display ≥4 
persisting nurse cell nuclei and each stage 14 egg chamber display an average of 6 
persisting nuclei (Figure 3.7B-C). Because Ced-12 deficiency mutations are lethal due to 
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the requirement for Ced-12 during border cell migration (Geisbrech et al., 2012), we 
knocked down Ced-12 expression only in the phagocytic follicle cells (GR1>Ced-12RNAi). 
In these Ced-12 mutants, approximately 94% of stage 14 egg chambers display ≥4 
persisting nurse cell nuclei, with an average of 7 persisting nuclei (Figure 3.20B-C). 
Impressively, in the CG31731Mi{MIC}/Mi{MIC}+GR1>Ced-12RNAi double mutants, 99.9% of 
the stage 14 egg chambers displayed ≥4 persisting nurse cell, and a considerable 
percentage of them completely failed to clear any of the nurse cell corpses (Figure 
3.20C). We were excited to find that the double mutants exhibited a much more severe 
engulfment defect than either single mutant alone. Similar to draperRNAi+Ced-12RNAi 
double knockdowns, CG31731Mi{MIC}/Mi{MIC}+GR1>Ced-12RNAi double mutants exhibit 
severely impaired engulfment mechanisms in a large majority of the egg chambers. These 
findings demonstrate that CG31731 acts in parallel to Ced-12, and its function is 
important for engulfment of the nurse cells. 
  To clarify whether CG31731 acts in the same pathway as Draper, we analyzed 
these double mutants. Our analyses of CG31731Mi{MIC}/Mi{MIC}+ draperΔ5double mutants 
compared to draperΔ5single mutants showed a similar phenotype between the two draper 
mutants. Respectively, 99.5% and 100% of stage 14 egg chambers from draperΔ5and 
CG31731Mi{MIC}/Mi{MIC}+draperΔ5mutants exhibited ≥4 persisting nurse cell nuclei (Figure 
3.21C), and both mutants displayed an average of approximately 9-10 persisting nurse 
cell corpses (Figure B). The similar engulfment defects observed between 
CG31731Mi{MIC}/Mi{MIC}+draperΔ5double mutants and draperΔ5mutants alone, indicate that 
CG31731 likely acts in the same pathway as Draper. 
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   The evolutionarily conserved engulfment mechanism implicates a role for ABC 
transporters, specifically those of the ABCA family. Consistent with CED-7/ABCA1 
acting in the same pathway as CED-1/MEGF10 and parallel to CED-12/ELMO 
(Mangahas and Zhou, 2005; Fullard et al., 2009), our double mutant analyses show that 
CG31731 acts in the same pathway as Draper and in parallel to Ced-12. Altogether, our 
findings thus far strongly suggests CG31731 may serve as the functional equivalent for 
CED-7/ABCA1 in Drosophila, and that the function of a CED-7-/ABCA1-like 
transporter is conserved in Drosophila through CG31731. 
3.8 CG31731 promotes Draper enrichment surrounding the nurse cells 
   During engulfment, CED-1/MEGF10 is observed to accumulate at the phagocytic 
cup and cluster around cell corpses (Zhou et al., 2001; Hamon et al., 2006). Presumably, 
in the presence of dying cells, CED-1/MEGF10 clusters at the phagocytic cup to 
recognize dying cells and facilitate their clearance. In vivo and in vitro studies in C. 
elegans and mouse cell culture respectively show that the uniform clustering of CED-
1/MEGF10 around cell corpses require CED-7/ABCA1 activity (Zhou et al., 2001; 
Hamon et al., 2006). Our analyses of CG31731 propose an orthologous function to ced-
7/ABCA1, suggesting that the CG31731 protein may similarly be required for Draper 
enrichment during engulfment of the nurse cells in oogenesis.  
   To examine whether CG31731 may function to promote Draper clustering around 
the nurse cells, we analyzed late stage egg chambers stained with anti-Draper antibody to 
label Draper, and DAPI to label DNA, from WT and CG31731Mi{MIC}/Mi{MIC} mutants. In 
WT late stage egg chambers, Draper staining becomes enriched specifically in the 
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phagocytic stretched follicle cells, and clearly surrounds each dying nurse cell (Figure 
3.22A) (Timmons et al., 2016). However, in CG31731Mi{MIC}/Mi{MIC} late stage egg 
chambers, Draper staining is disorganized, unevenly enriched in the stretched follicle 
cells, and scattered around the nurse cells (Figure 3.22B). Even more strikingly, in some 
areas Draper staining is completely absent around the nurse cells. These observations 
indicate that in CG31731Mi{MIC}/Mi{MIC} egg chambers, Draper fails to properly accumulate 
on the stretched follicle cell membranes and encircle the dying nurse cells, suggesting a 
role for CG31731 in Draper clustering at the phagocytic cup. 
   Draper functions as a recognition receptor of dying cells on the surface of 
phagocytic cells (Freeman et al., 2003). The lack of Draper staining in some areas of 
CG31731Mi{MIC}/Mi{MIC} egg chambers suggests that Draper is absent from the stretched 
follicle cells, and thus Draper-mediated recognition of the dying nurse cells is not 
achieved,  resulting in their persistence. Consistent with Draper known to normally 
localize to the membrane of engulfing cells, we detected normal Draper staining along 
the follicle cell membranes of mid-stage egg chambers, suggesting Draper localization to 
the follicle cell membrane is not disrupted. In the mere failure of Draper accumulation 
around the nurse cells, Draper staining should still be detected in the stretched follicle 
cells. Therefore we speculate that perhaps in areas lacking Draper staining, the stretched 
follicle cells failed to extend and reach the nurse cells, and are themselves absent. 
Consistent with this hypothesis, when draper is knocked down specifically in the follicle 
cells, some nurse cells do not appear to be surrounded by the stretched follicle cells 
(Timmons et al, 2016). It is speculated that CED-7 with CED-1 and DYN-1 may function 
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to promote intracellular vesicle delivery to the membrane to provide lipid and protein 
sources to the growing phagocytic cup (Zhou et al., 2008). Perhaps in 
CG31731Mi{MIC}/Mi{MIC} mutants and in draperRNAi mutants, a lack of membrane material at 
the growing phagocytic cup prevents the stretched follicle cells from extending and 
reaching some nurse cells. This would explain the areas lacking Draper staining, which 
appear to be farthest from the stretched follicle cells spanning the outer limits of the egg 
chamber. 
3.9 CG31731 has a role in acidification of the nurse cells 
   Previous work in our lab has shown that in addition to recognition of the dying 
nurse cells, Draper activity in the follicle cells is also required for acidification and 
subsequent degradation of the nurse cells (Timmons et al., 2016). Since Draper 
enrichment and clustering around the nurse cells is disrupted in CG31731Mi{MIC}/Mi{MIC} 
mutants,  we wondered whether acidification of the nurse cells was also disrupted in 
these mutants. We looked at egg chambers stained with LysoTracker to label acidified 
compartments, and DAPI to label DNA, from WT and CG31731Mi{MIC}/Mi{MIC} mutants. In 
WT developing egg chambers, LysoTracker-positive nurse cells can be detected in stage 
12-14 egg chambers (Figure 3.23A/C). The majority of the nurse cells become acidified 
in stage 12 egg chambers, and by stage 13, almost all the nurse cells have been acidified 
and cleared with only a few remaining in the LysoTracker or DAPI channel. By stage 14, 
all the nurse cells appear to have been acidified and cleared, with occasionally a few 
detected in the LysoTracker channel but no nurse cell nuclei detected in the DAPI 
channel (Figure 3.23A). Noticeably, LysoTracker-positive staining visibly corresponds to 
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a reduction and sometimes absence in DAPI staining of the nurse cell nuclei, suggesting 
that the acidification of the nurse cell nuclei is directly associated with their degradation 
and subsequent clearance by our quantification methods.  
   In comparison, in CG31731Mi{MIC}/Mi{MIC} mutants LysoTracker staining is 
disrupted, although not completely blocked. Compared to WT where approximately 77% 
of stage 12 egg chambers exhibit a substantial amount of LysoTracker-positive nurse 
cells, in CG31731Mi{MIC}/Mi{MIC} mutants over 85% of stage 12 egg chambers do not 
exhibit any LysoTracker staining (Figure 3.23C). Intriguingly, a slightly higher 
percentage of stage 13 and stage 14 CG31731Mi{MIC}/Mi{MIC} egg chambers compared to 
WT exhibit LysoTracker-positive staining, suggesting in these mutants acidification of 
the nurse cells is delayed. In CG31731Mi{MIC}/Mi{MIC} late stage egg chambers that do 
exhibit LysoTracker staining, a markedly fewer number of nurse cells are LysoTracker-
positive and most of the stage 14 persisting nuclei do not appear to become acidified, 
suggesting acidification may be blocked in these persisting nuclei. Since our observations 
in WT egg chambers illustrated a direct link between acidification, degradation, and 
clearance of the nurse cells, it makes sense that all these events are blocked in uncleared 
persisting nuclei. Altogether, these observations suggest CG31731 has a role in 
promoting acidification of the nurse cells for their effective removal. 
   We showed that in CG31731Mi{MIC}/Mi{MIC} mutants, Draper fails to properly 
accumulate around the dying nurse cells. Previous work from our lab has shown that 
LysoTracker staining of the nurse cells requires Draper activity (Timmons et al., 2016). 
We speculated that perhaps the delay in nurse cell acidification in CG31731Mi{MIC}/Mi{MIC} 
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egg chambers results from abnormal Draper activity. However, the acidification defect in 
draperRNAi egg chambers was found to be much more pronounced with acidification 
blocked rather than delayed in over 70% of egg chambers (Timmons et al., 2016), 
suggesting that in CG31731Mi{MIC}/Mi{MIC} egg chambers the function of Draper is not 
completely disrupted since acidification proceeds relatively normally in stage 13-14 egg 
chambers. Therefore the lack of acidified nurse cells in most stage 12 egg chambers and 
in persisting nuclei in CG31731Mi{MIC}/Mi{MIC} mutants is unlikely a direct result of 
changes in Draper activity. Instead, the acidification of nurse cells appears to be 
coordinated by lysosomal machinery, including V-ATPases, on the stretched follicle cell 
membrane (personal communication, Albert Mondragon). If in CG31731Mi{MIC}/Mi{MIC} 
mutants the stretched follicle cells fail to surround some nurse cells, lysosomal machinery 
on the stretched follicle cell membrane would not surround these nurse cells. This would 
explain their lack of acidification and their subsequent persistence. Alternatively, if 
CG31731 is required for intracellular trafficking of vesicles to the membrane, perhaps 
CG31731 is also required for intracellular trafficking of lysosomal machinery, including 
V-ATPases, to the stretched follicle cell membrane. While more experiments need to be 
undertaken to elucidate the precise role of CG31731 in engulfment and processing of the 
nurse cells, we have shown that CG31731 is required for the acidification, subsequent 
degradation, and clearance of the nurse cells.  
3.10 CG31731 is required in the follicle cells for engulfment during induced PCD 
   The engulfment mechanism regulated by the ced-1/-6/-7 and ced-2/-5/-12 
pathways is important in engulfing cells for efficient clearance of cell corpses in multiple 
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PCD systems in C. elegans (Mangahas and Zhou, 2005). Likewise, our lab has previously 
shown that the draper and Ced-12 pathways in Drosophila are required in phagocytic 
cells in at least two distinct PCD events in the ovary, in developmental PCD during 
which the nurse cells undergo phagoptosis, and in starvation-induced PCD during which 
the nurse cells undergo apoptosis and autophagic cell death (Etchegaray et al., 2012; 
Jenkins et al, 2013; Timmons et al, 2016). We have shown that CG31731 is required in 
the phagocytic follicle cells during developmental PCD for proper removal of the nurse 
cells. To determine whether CG31731 is similarly conserved in another PCD system, we 
investigated its role during starvation-induced PCD in the ovary. 
   We selected CG31731Mi{MIC}/- and follicle cell specific CG31731RNAi-GD1133 
mutants, which show the strongest persisting nurse cell nuclei phenotype, and starved the 
adults for a 16-20 hour period to induce PCD in mid-stage egg chambers. Subsequently, 
we dissected and stained the ovaries with anti-Dlg to label follicle cell membranes, anti-
cleaved Dcp-1 to label active caspases and apoptotic germline debris, and DAPI to label 
DNA, and observed egg chambers from each phase as sorted by the changes in nurse cell 
chromatin (Figure 3.22). Healthy phase 0 egg chambers resembled the control, suggesting 
that CG31731 mutant egg chambers develop normally through mid-oogenesis. Phase 1-2 
dying egg chambers also resembled the control, appearing to initiate PCD normally. 
While phase 3 dying egg chambers exhibited slightly enlarged follicle cells, they 
appeared to only minimally uptake the germline material with fewer engulfed Dcp-1 
positive vesicles present inside the follicle cells. Nevertheless, the follicle cells were still 
able to engulf some nurse cell debris and nurse cell nuclei could be seen inside the 
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follicle cells. Some of these engulfed nurse cell nuclei only faintly stained with DAPI, 
suggesting they have been acidified for degradation. By phase 4-5, these CG31731 
mutant dying egg chambers exhibited severe engulfment defects and premature follicle 
cell death.  The few intact healthy-looking follicle cells exhibiting dispersed chromatin 
were enlargement defective, and majority of the follicle cells exhibited pyknotic nuclei 
without any membrane markers. In these phase 5 dying egg chambers, follicle cell 
membranes and nuclei disappear, leaving behind egg chambers with completely 
unengulfed germline material. The majority of the dying egg chambers found in the 
ovaries of CG31731 mutants were these phase 5 egg chambers, indicating a pronounced 
defect in corpse clearance. These observations signify severe impairments in the 
engulfment machinery, and illustrate an important role for CG31731 in the follicle cells 
to ensure proper enlargement of the follicle cells in engulfment. We did not observe any 
obvious engulfment defects in dying egg chambers when CG31731RNAi-GD1133 or 
CG31731RNAi-HMS06027 was expressed only in the germline (data not shown), suggesting 
CG31731 function is primarily required in the phagocytic follicle cells during engulfment 
of the dying germline material. 
3.11 CG31731 is unlikely to act in neuronal corpses or engulfing glia in the brain 
   Our studies of CG31731 thus far have focused on PCD events in the ovary, where 
we found it is required in the phagocytic follicle cells for clearance of the germline 
debris. We were curious to know whether CG31731 may also be involved in other PCD 
systems in Drosophila. To explore a potential role for CG31731 outside the ovary, we 
looked in the brain, where engulfing glia are responsible for the clearance of degenerating 
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axons. It has been demonstrated that ensheathing glia require components of the Draper 
pathway for engulfment of axonal debris (Freeman et al., 2003; MacDonald et al., 2006; 
Kurant, 2011; Etchegaray et al., 2016).  Our experiments in the ovary strongly suggest 
that CG31731 is a key component of the Draper pathway. Therefore, perhaps CG31731 
may also have a role with Draper in the brain. 
    Previous work in the lab has endeavored to characterize PCD in the brain. In WT 
brains stained with DAPI to label DNA, healthy neuronal nuclei show dispersed DNA 
with a single condensed spot corresponding to heterochromatin. In contrast, in brains 
which exhibit defective glial phagocytosis, for example in draperΔ5mutants, a substantial 
number of neuronal nuclei appear highly condensed into single balls, indicating pyknosis. 
TUNEL labeling in draperΔ5 brains shows that the presence of these pyknotic nuclei 
correspond to approximately 700 TUNEL-positive corpses. In comparison, WT brains 
only exhibit 1 or 2 TUNEL-positive corpses (Etchegaray et al., 2016).  Using the same 
methods, we looked at CG31731Mi{MIC}/Mi{MIC} brains stained with DAPI to label DNA 
and TUNEL to label fragmented DNA, and did not observe any obvious signs of 
defective glial phagocytosis. In CG31731Mi{MIC}/Mi{MIC} brains, the chromatin morphology 
of neurons appeared similar to those in WT brains and there was no accumulation of 
pyknotic nuclei. TUNEL labeling only detected a single apoptotic corpse, which is 
normal (Figure 2.24). These results suggest that CG31731 does not have a role in PCD 
and engulfment in the Drosophila brain. This may not be unexpected given that CG31731 
is expressed at much lower levels in the brain compared to in the ovary (Flybase). In 
humans, there are multiple functional homologs for CED-7 including ABCA1 and 
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ABCA7. We speculate that perhaps another ABCA gene, not CG31731 or CG1718 
(Ziegenfuss, 2012), provides an ABCA transporter role for glia-mediated neuronal corpse 
clearance in the Drosophila brain. 
3.12  Summary of findings 
Here, we report that Drosophila CG31731 encodes an ABC transporter similar to 
ced-7/ABCA1. Like ced-7/ABCA1, the CG31731 gene encodes an ABCA type 
transporter. Sequence alignment shows that the predicted polypeptide possesses 
substantial similarity and identity to that of CED-7/ABCA1. More importantly, our 
genetic analyses identify a role for CG31731 in cell corpse clearance during PCD in the 
Drosophila ovary in vivo.  
 To observe a role for CG31731 in engulfment, we looked at 2 distinct PCD 
modalities in the ovary, in late stage developing and in mid-stage dying egg chambers. 
During the development of every egg chamber, 15 nurse cells are selectively removed by 
the surrounding phagocytic stretched follicle cells between stages 12-14 (Jenkins et al., 
2013). It has been shown that phagocytosis genes in the stretched follicle cells non-
autonomously regulate the death of the nurse cells, likely via phagoptosis (Timmons et 
al., 2016). Additionally, during starved conditions, mid-stage egg chambers can be 
induced to activate apoptotic and autophagic cell death pathways (Jenkins et al., 2013). In 
these mid-stage dying egg chambers, the surrounding follicle cells synchronously enlarge 
through 5 phases of death to engulf the dead germline debris (Etchegaray et al., 2012).  
Using the Drosophila ovary as an in vivo model system, we show that genetically 
knocking down CG31731 specifically in the phagocytic follicle cells leads to engulfment 
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defects in both late stage developing and mid-stage dying egg chambers. In late 
oogenesis, engulfment defects are apparent in egg chambers that fail to clear all 15 dying 
nurse cells by stage 14. Similarly, in mid-oogenesis, engulfment defects are evident in 
dying mid-stage egg chambers that fail to engulf the dead germline debris by phase 5. In 
contrast, genetically repressing CG31731 expression only in the dying nurse cells did not 
lead to any obvious engulfment defects in either system of PCD. Together, these 
observations in 2 distinct PCD modalities demonstrate a conserved role for CG31731 
specifically in the phagocytic cells for cell corpse clearance. 
Other core components of the engulfment machinery, including draper and Ced-
12, have previously been shown to also be required in the phagocytic follicle cells for 
removal of the dying nurse cells (Timmons et al., 2016). Our double mutant analyses of 
CG31731Mi{MIC}/Mi{MIC} with draperΔ5or Ced-12RNAi show that CG31731 likely acts in the 
same pathway as draper, parallel to Ced-12. Correspondingly, ced-7/ABCA1 acts in the 
same pathway as ced-1/MEGF10, parallel to ced-12/ELMO (Mangahas and Zhou, 2005), 
strongly suggesting CG31731 provides a ced-7/ABCA1-like role in this conserved 
engulfment mechanism. Moreover, as ced-7/ABCA1 was demonstrated to be required for 
CED-1/MEGF10 clustering at the phagocytic cup, we similarly observed a disruption in 
Draper enrichment around the nurse cells in CG31731 mutants. Altogether, these findings 
identify a functional relation between ced-7/ABCA1 and CG31731 in signaling events 
during engulfment. 
A prominent feature in the removal of nurse cells during developmental PCD is 
the acidification and subsequent clearance of the nurse cell nuclei. In WT developing egg 
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chambers, majority of the nurse cells are acidified in stage 12 and cleared even before 
stage 14. In contrast, in draperΔ5mutants, acidification is completely blocked in 
approximately 70% of developing egg chambers (Timmons et al., 2016). Our 
observations suggest in CG31731Mi{MIC}/Mi{MIC} mutants, acidification only occurs in the 
few cleared nurse cells and is delayed to stage 13.  Acidification appears to be blocked in 
persisting nurse cell nuclei. These observations are very similar to those in ced-1 pathway 
mutants in C. elegans, wherein engulfment is delayed and blocked in some corpses, and 
degradation is delayed in engulfed corpses. Taken together, these similar defects in PCD 
observed between homologous genes in Drosophila and C. elegans demonstrate a 
conserved engulfment and possibly degradation mechanism of cell corpses involving 
CG31731 in Drosophila. 
We also observed a role for CG1718, another ABCA gene in Drosophila. Most 
noticeably, in the lack of a WT CG31731 allele, our data suggests CG1718 may provide a 
compensatory function for CG31731. This observation leads us to speculate that perhaps 
there are multiple ced-7 homologs in Drosophila. Moreover, we did not observe a role for 
CG31731 in neuronal corpse clearance, and a separate lab also did not observe a role for 
CG1718 in engulfing glia (Ziegenfuss, 2012), suggesting there is perhaps yet another 
ced-7/ABCA1 ortholog that is involved in PCD events in the Drosophila brain. In 
mammals ABCA1 and ABCA7 appear to provide redundant functions for lipid efflux in 
some tissues (Hamon et al., 2000; Wang et al., 2003), supporting the possibility for 
redundancy between ABCA type transporters. 
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   In summary, we have shown that CG31731, an ABCA encoding gene, plays a 
similar role to ced-7/ABCA1 during engulfment and PCD events in the Drosophila ovary. 
As the evolutionarily conserved engulfment mechanism implicates a role for ABC 
transporters, our findings strongly suggest CED-7/ABCA1 is conserved in Drosophila 
through at least CG31731, and perhaps other unidentified ABCA transporters as well.  
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Table 3.1 Quantification of persisting nuclei 
Very Strong 75%-100% stage 14 egg chambers have >4 PN 
Strong 50%-75% stage 14 egg chambers have >4 PN 
Moderate 25%-50% stage 14 egg chambers have >4 PN 
Weak 10%-25% stage 14 egg chambers have >4 PN 
None 0%-10% stage 14 egg chambers have >4 PN 
 
Genotype 
0 
PN 
1-3 
PN 
4-6 
PN 
7-9 
PN 
10-12 
PN 
13-15 
PN 
n 
w1118 0.90 0.10 0.00 0.00 0.00 0.00 124 
CG31731PBac/PBac 0.39 0.27 0.23 0.10 0.01 0.00 302 
CG31731PBac/- 0.06 0.14 0.34 0.32 0.12 0.02 113 
CG31731Mi{MIC}/Mi{MIC} 0.15 0.11 0.22 0.35 0.15 0.01 136 
CG31731Mi{MIC}/- 0.01 0.03 0.21 0.44 0.27 0.04 567 
CG31731PBac/Mi{MIC} 0.07 0.15 0.24 0.33 0.17 0.04 410 
CG31731P{EPgy2}/PBac 0.90 0.10 0.00 0.00 0.00 0.00 702 
CG31731P{EPgy2}/Mi{MIC} 0.96 0.04 0.00 0.00 0.00 0.00 243 
CG31731P{EPgy2}/- 0.94 0.06 0.00 0.00 0.00 0.00 328 
CG31731PBac/+ 0.88 0.09 0.02 0.00 0.00 0.00 86 
CG31731Mi{MIC}/+ 0.77 0.17 0.05 0.01 0.00 0.00 144 
CG31731P{EPgy2}/+ 0.94 0.05 0.01 0.00 0.00 0.00 89 
CG31731Δ/+ 0.80 0.20 0.00 0.00 0.00 0.00 102 
PG150-GAL4/UAS-CG31731P{EPgy2} 0.96 0.04 0.00 0.00 0.00 0.00 212 
GR1-GAL4/UAS-CG31731P{EPgy2} 0.97 0.03 0.00 0.00 0.00 0.00 520 
nanos-GAL4/UAS-CG31731P{EPgy2} 1.00 0.00 0.00 0.00 0.00 0.00 1259 
PG150-GAL4/UAS-CG31731RNAi-GD1133 0.82 0.16 0.01 0.00 0.00 0.00 422 
PG150-GAL4/UAS-CG31731RNAi-KK104197 0.95 0.05 0.00 0.00 0.00 0.00 209 
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PG150-GAL4/UAS-CG31731RNAi-HMC06027 0.96 0.01 0.03 0.00 0.00 0.00 81 
GR1-GAL4 G89/UAS-CG31731RNAi-GD1133  0.04 0.11 0.33 0.34 0.15 0.03 784 
GR1-GAL4 G89/UAS-CG31731RNAi-KK104197  0.05 0.28 0.40 0.22 0.04 0.00 459 
GR1-GAL4 G89/UAS-CG31731RNAi-HMC06027 0.04 0.30 0.44 0.22 0.00 0.00 27 
nanos-GAL4/UAS-CG31731RNAi-GD1133  0.89 0.11 0.00 0.00 0.00 0.00 122 
nanos-GAL4/UAS-CG31731RNAi-KK104197  0.94 0.06 0.00 0.00 0.00 0.00 105 
nanos-GAL4/UAS-CG31731RNAi-HMC06027 0.97 0.03 0.00 0.00 0.00 0.00 73 
GR1-GAL4 G89/UAS-Ced-12RNAi 0.01 0.05 0.27 0.49 0.17 0.01 288 
CG31731Mi{MIC}/Mi{MIC} +  
GR1-GAL4 G89/UAS-dced-12RNAi 
0.00 0.00 0.01 0.20 0.56 0.23 697 
draperΔ5 0.00 0.01 0.08 0.40 0.41 0.10 192 
CG31731Mi{MIC}/Mi{MIC} + draperΔ5 0.00 0.00 0.09 0.55 0.34 0.02 491 
nanos-GAL4/UAS-CG1718RNAi-HMS01821 0.98 0.02 0.00 0.00 0.00 0.00 128 
nanos-GAL4/UAS-CG1718RNAi-HMS01796 0.98 0.02 0.00 0.00 0.00 0.00 185 
nanos-GAL4/UAS-CG1718RNAi-GD3708(49) 0.98 0.02 0.00 0.00 0.00 0.00 169 
nanos-GAL4/UAS-CG1718RNAi-GD3708(51) 0.99 0.01 0.00 0.00 0.00 0.00 302 
nanos-GAL4/UAS-CG1718RNAi-KK100452 0.97 0.03 0.00 0.00 0.00 0.00 186 
GR1-GAL4 G89/UAS-CG1718RNAi-HMS01821 0.23 0.32 0.33 0.11 0.01 0.00 230 
GR1-GAL4 G89/UAS-CG1718RNAi-HMS01796 0.94 0.06 0.00 0.00 0.00 0.00 254 
GR1-GAL4 G89/UAS-CG1718RNAi-GD3708(49) 0.99 0.01 0.00 0.00 0.00 0.00 1118 
GR1-GAL4 G89/UAS-CG1718RNAi-GD3708(51) 0.98 0.02 0.00 0.00 0.00 0.00 92 
GR1-GAL4 G89/UAS-CG1718RNAi-KK100452 0.97 0.03 0.00 0.00 0.00 0.00 1631 
GR1-GAL4 G89/UAS-CG1718RNAi-HMS01821, 
UAS-CG31731P{EPgy2} 
0.11 0.59 0.30 0.00 0.00 0.00 63 
CG1718miR-1007-KO/miR-1007-KO 0.84 0.13 0.02 0.01 0.01 0.00 171 
CG1718miR-1007-KO/miR-1007-K + CG31731PBac/ PBac 0.01 0.16 0.38 0.34 0.11 0.00 238 
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Figure 3.1 CG31731, CG1718, CED-7, and ABCA1 protein domains 
 
A 
 
B 
 
C 
 
D 
 
 
 
Schematic of the primary structures of (A) CG31731, (B) CG1718, (C) CED-7, and (D) 
ABCA1. The transmembrane segments (grey) and NBDs (red) are shown.  
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Figure 3.2 CG31731 predicted amino acid sequence aligned with ced-7 and ABCA1
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Alignment of the predicted amino acid sequences of Drosophila CG31731, C. elegans 
CED-7, and human ABCA1. The similarities (light grey) and identities (dark grey) 
between the three sequences are highlighted. The highly conserved A-loop, Walker A 
motif, Q- loop, ABC signature motif, Walker B motif, D-loop, and H-loop, are indicated 
(red). (Sequence alignment provided by UniProt.org) 
 
 
92 
 
   
 
Figure 3.3 CG1718 predicted amino acid sequence aligned with ced-7 and ABCA1
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Alignment of the predicted amino acid sequences of Drosophila CG1718, C. elegans 
CED-7, and human ABCA1. The similarities (light grey) and identities (dark grey) 
between the three sequences are highlighted. The highly conserved A-loop, Walker A 
motif, Q- loop, ABC signature motif, Walker B motif, D-loop, and H-loop, are indicated 
(red). (Sequence alignment provided by UniProt.org)  
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Figure 3.4 CG31731 gene region 
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CG31731 gene region. The CG31731 gene extends from 13,784,084–13,790,562. The 
location of the insertions: P{EPgy2} at 13,784,172, PBac at 13,784,330, and Mi{MIC} at 
13,784,705, are depicted (red line). The gene span (xxxx), RNA (XXXX), and coding 
exons (XXXX) are shown. (Sequence obtained from Flybase) 
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Figure 3.5 CG31731 gene map and transgenic constructs 
A 
 
B 
 
 
(A)  Schematic of the CG31731 gene region on chromosome 2L. The CG31731 gene 
(dark blue) extends from 13,784,084–13,790,562. The translated regions (light blue) and 
untranslated regions (grey) in the 2 mRNA transcripts, CG31731-RC and CG31731-RB, 
and the locations of the transgenic insertions (purple) and RNAi target sites (green) are 
mapped. (Figure modified from Flybase) 
(B)  Structure of transgenic constructs.  The P{EPgy2} construct carries two visible 
markers, the mini-white marker and the mini-yellow marker, and UAS binding sites for 
the GAL4 transcriptional regulator, adjacent to GAGA sites and upstream of the 
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promoter.  The PBac{WH} construct carries the mini-white marker, Su(Hw) insulator 
sequences, a long (199-bp) FRT site for FLP-mediated recombination, and a terminal 
UAS site for GAL4-driven misexpression of adjacent genes.  The Mi{MIC} construct is 
flanked by two Minos inverted repeats (L and R) and two inverted attP sites (P), and 
carries the mini-yellow marker, an EGFP coding sequence with a polyadenylation signal 
(pA), and a mutagenic gene-trap cassette consisting of a splice acceptor site (SA) 
followed by stop codons in all three reading frames. Elements are not drawn to scale and 
are meant only to indicate the components in each construct. Arrows indicate direction of 
transcription. (Figures modified from Bellen et al., 2011 and Venken et al., 2015) 
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Figure 3.6 CG1718 gene map 
 
Schematic of the CG1718 gene region on chromosome X. The CG1718 gene (dark blue) 
extends from 21,292,308–21,306,665. The translated regions (light blue) and untranslated 
regions (grey) in the 3 mRNA transcripts, CG1718-RB, CG1718-RC, and CG1718-RD, 
and the locations of the RNAi target sites (green) are mapped. The miR-1007 gene (dark 
blue) is also shown with the location of the miR-1007 deletion (red) generated via 
targeted homologous recombination. (Figure modified from Flybase) 
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Figure 3.7 CG31731 insertional mutations, CG31731PBac and CG31731Mi{MIC}, have 
persisting nurse cell nuclei 
A    
 
B                
 
C 
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(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, from wild-type 
(WT) or CG31731 transgenic mutants. WT (w1118) egg chambers successfully complete 
PCD and do not have persisting nurse cell nuclei. Homozygous CG31731PBac/ PBac and 
CG31731Mi{MIC}/ Mi{MIC} mutants, and hemizygotes in trans to a deficiency allele (Δ) have 
defects in nurse cell clearance and have persisting nuclei (arrows). 
(B)  The average number of persisting nuclei (PN) in stage 14 egg chambers from each 
genotype: WT ~0, CG31731PBac/ PBac ~2-3, CG31731PBac/- ~6,  CG31731Mi{MIC}/ Mi{MIC} ~6, 
CG31731Mi{MIC}/- ~8,  and CG31731PBac/Mi{MIC} ~6. Error bars indicate ±SEM. 
(C)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype.  
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Figure 3.8 The P{EPgy2} insertional mutation does not disrupt CG31731 
A B 
   
 
(A)  Stage 14 egg chamber, stained with DAPI (blue) to label DNA, from a 
CG31731P{EPgy2}/- hemizygous mutant, does not exhibit persisting nurse cell nuclei. 
(B) Quantification of the persisting nuclei (PN) in CG31731P{EPgy2} heterozygous mutants 
in trans to a CG31731PBac or CG31731Mi{MIC} allele, and hemizygous mutants in trans to a 
a deficiency (Δ). None of these CG31731P{EPgy2} mutants appear to have defects in nurse 
cell clearance as stage 14 egg chambers do not exhibit a persisting nuclei phenotype. The 
percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 10-12 
PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype is shown.  
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Figure 3.9 Over-expression of CG31731 with P{EPgy2} in the follicle cells, stretched 
follicle cells, or nurse cells, does not disrupt nurse cell clearance 
A 
 
B 
 
 
(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, with GAL4 
predicted to over-express CG31731 specifically in the follicle cells (GR1-GAL4/UAS-
CG31731P{EPgy2}), stretched follicle cells (PG150-GAL4/UAS-CG31731P{EPgy2}), or nurse 
cells (nanos-GAL4/UAS-CG31731P{EPgy2}), do not have persisting nurse cell nuclei. 
(B)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype. 
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Figure 3.10 CG31731 is not haploinsufficient  
 
 
 
Quantification of the persisting nuclei in CG31731 heterozygous transgenic or deficiency 
mutants in trans to a WT CG31731 allele (Cyo balancer). None of these mutants appear 
to have defects in nurse cell clearance as stage 14 egg chambers do not have a persisting 
nuclei phenotype. The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 
PN, 7-9 PN, 10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype is 
shown.  
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Figure 3.11 Knockdown of CG31731 in the stretched follicle cells does not disrupt 
nurse cell clearance 
A  
 
B 
 
 
(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, from draperRNAi or 
one of 3 different CG31731RNAi constructs (GD1133, KK104197, HMC06027)  expressed 
specifically in the stretched follicle cells (PG150-GAL4/UAS-draperRNAior CG31731RNAi). 
Control draperRNAi expressing stage 14 egg chambers have persisting nuclei (arrow). 
CG31731RNAi expressing stage 14 egg chambers do not have persisting nuclei. 
(B) The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype. 
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Figure 3.12 CG31731 is required in the follicle cells for nurse cell clearance 
 
A                 
 
 
B           C            
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(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, from control or one 
of 3 different CG31731RNAi constructs (GD1133, KK104197, HMC06027)  expressed 
specifically in the follicle cells (GR1-GAL4 G89/UAS-CG31731RNAi). Sibling control 
(TM6B/UAS-CG31731RNAi) egg chambers sucessfully complete PCD and do not have 
persisting nurse cell nuclei. RNAi-expressing egg chambers fail to complete PCD and 
have persisting nuclei (arrows). 
(B)  The average number of persisting nuclei (PN) in stage 14 egg chambers from each 
genotype: control ~0, GR1>GD1133 ~7, GR1>KK10419 ~5, GR1>HMC06027 ~4-5. Error 
bars indicate ±SEM.  
(C)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype. 
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Figure 3.13 Predicted over-expression of CG31731 with P{EPgy2} does not rescue 
the defects in nurse clearance in egg chambers expressing CG31731RNAi specifically 
in the follicle cells 
 
 
Quantification of the persisting nurse cell nuclei in egg chambers expressing one of 2 
different CG31731RNAi constructs (GD1133, KK104197)  specifically in the follicle cells 
(GR1-GAL4 G89/UAS-CG31731RNAi) and simultaneously over-expressing CG31731 
specifically in the follicle cells (GR1-GAL4 G89/UAS-CG31731P{EPgy2}). The 
simultaneous expression of CG31731RNAi and CG31731P{EPgy2} specifically in the follicle 
cells results in a similar engulfment defect observed in egg chambers only expressing 
CG31731RNAi. The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 
7-9 PN, 10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype is 
shown. 
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Figure 3.14 CG31731 is not required in the nurse cells for their clearance 
A  
    
B 
 
 
(A)  Control egg chambers express GFP specifically in the nurse cells (nanos-GAL4/UAS-
GFP). Stage 14 egg chamber, stained with DAPI (blue) to label DNA, from one of 3 
different CG31731RNAi constructs (GD1133, KK104197, HMC06027)  expressed specifically in 
the nurse cells (nanos-GAL4/UAS-CG31731RNAi) does not have persisting nuclei.  
(B)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype.  
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Figure 3.15 CG1718 is not required in the nurse cells for their clearance 
 
 
 
Quantification of the persisting nuclei in egg chambers expressing one of 5 different 
CG1718RNAi constructs (HMS01821, HMS01796, GD3708(stock # 44449), GD3708(stock # 
44451), KK100452) expressed specifically in the nurse cells (nanos-Gal/UAS-CG1718RNAi). 
None of these knockdowns appear to have defects in nurse cell clearance as stage 14 egg 
chambers do not have a persisting nuclei phenotype. The percentage of stage 14 egg 
chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 10-12 PN, 13-15 PN, of all stage 14 
egg chambers quantified per genotype is shown. 
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Figure 3.16 CG1718 may be required in the follicle cells for nurse cell clearance 
A 
 
 
B 
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(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, from control or one 
of 5 different CG1718RNAi constructs (HMS01821, HMS01796, GD3708(stock # 44449), 
GD3708(stock # 44451), KK100452) expressed specifically in the follicle cells (GR1-GAL4 
G89/UAS-CG1718RNAi). Control (TM6B/UAS-CG1718RNAi) stage 14 egg chambers 
sucessfully complete PCD and do not have persisting nuceli. Some HMS01821 RNAi 
expressing egg chambers have persisting nuclei (arrow). Egg chambers expressing one of 
the other RNAi constructs do not have persisting nuclei.  
(B)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype   
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Figure 3.17 Predicted over-expression of CG31731 with P{EPgy2} does not rescue 
the defects in nurse clearance in egg chambers expressing CG1718RNAi-HMS01821 
specifically in the follicle cells 
 
A 
 
 
B                 C      
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(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, from CG1718RNAi-
HMS01821 expressed specifically in the follicle cells (GR1-GAL4 G89/UAS-CG1718RNAi-
HMS01821), CG31731 predicted to be over-expressed specifically in the follicle cells (GR1-
 
 
116 
 
   
 
GAL4 G89/UAS-CG31731P{EPgy2}), or these double mutants. Persisting nuclei are 
indicated (arrows). 
(B)  The average number of persisting nuclei (PN) in stage 14 egg chambers from each 
genotype: GR1> CG1718RNAi-HMS01821 ~3, GR1>CG31731P{EPgy2} ~0, GR1> CG1718RNAi-
HMS01821+CG31731P{EPgy2} ~2-3. Error bars indicate ±SEM  
(C)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype. 
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Figure 3.18 CG1718miR-1007-KO/ miR-1007-KO+CG31731PBac/ PBac double mutants have a 
more severe persisting nuclei phenotype than either CG1718miR-1007-KO/ miR-1007-KO or 
CG31731
PBac/ PBac mutants alone 
 
A 
 
 
B                C 
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(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, from CG1718miR-
1007-KO/miR-1007-KO mutants, CG31731PBac/ PBac mutants, or these double mutants.  
CG1718miR-1007-KO/miR-1007-KO egg chambers do not have persisting nurse cell nuclei. 
CG31731PBac/ PBac and CG1718miR-1007-KO/miR-1007-K+CG31731PBac/ PBac double mutants have 
persisting nuclei (arrows). 
(B)  The average number of persisting nuclei (PN) in stage 14 egg chambers from each 
genotype: CG1718miR-1007-KO/miR-1007-KO ~0, CG31731PBac/ PBac ~2-3, CG1718miR-1007-KO/miR-
1007-KO+CG31731PBac/ PBac ~6. Error bars indicate ±SEM. 
(C)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype. 
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Figure 3.19 CG31731Mi{MIC}/Mi{MIC}+GR1>Ced-12RNAi double mutants have a more 
severe persisting nuclei phenotype than either CG31731Mi{MIC}/Mi{MIC} or GR1>Ced-
12
RNAi mutants alone 
 
A 
 
 
B           C 
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(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, from control,  
CG31731Mi{MIC}/Mi{MIC} mutants, Ced-12RNAi expressed specifically in the follicle cells 
(GR1-GAL4 G89/UAS-Ced-12RNAi), or these double mutants. Control (TM6B/UAS-Ced-
12RNAi) stage 14 egg chambers successfully complete PCD and do not have persisting 
nurse cell nuclei. The CG31731Mi{MIC}/Mi{MIC} and  Ced-12RNAi expressing egg chambers 
chambers have persisting nuclei (arrows).  
(B)  The average number of persisting nuclei (PN) in stage 14 egg chambers from each 
genotype: control ~0, CG31731Mi{MIC}/Mi{MIC} ~6,  GR1>Ced-12RNAi ~7, 
CG31731Mi{MIC}/Mi{MIC}+GR1>Ced-12RNAi ~11.  Error bars indicate ±SEM.  
(C)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype. 
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Figure 3.20 CG31731Mi{MIC}/Mi{MIC} +draperΔ5double mutants have a similar persisting 
nuclei phenotype to draperΔ5mutants alone  
 
A 
 
 
B           C 
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(A)  Stage 14 egg chambers, stained with DAPI (blue) to label DNA, from wild-type 
(WT),  CG31731Mi{MIC}/Mi{MIC} mutants, draperΔ5mutants, or these double mutants. WT 
(w1118) stage 14 egg chambers successfully complete PCD and do not have persistng 
nurse cell nuclei. CG31731Mi{MIC}/Mi{MIC} and  draperΔ5stage 14 egg chambers have 
persisting nuclei (arrows).  
(B)  The average number of persisting nuclei (PN) in stage 14 egg chambers from each 
genotype: WT ~0, homozygous CG31731Mi{MIC}/Mi{MIC} ~6,  draperΔ5~9-10, 
CG31731Mi{MIC}+ draperΔ5~9. Error bars indicate ±SEM.  
(C)  The percentage of stage 14 egg chambers exhibiting 0 PN, 1-3 PN, 4-6 PN, 7-9 PN, 
10-12 PN, 13-15 PN, of all stage 14 egg chambers quantified per genotype. 
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Figure 3.21 CG31731 promotes Draper enrichment surrounding the nurse cells 
     
(A-B) Late-stage egg chambers, stained with anti-Draper antibody (green) to label 
Draper, and DAPI (cyan) to label DNA, from WT or CG31731Mi{MIC}/Mi{MIC} mutants.  
(A)  In WT (w1118) late-stage egg chambers, Draper is evenly enriched in the stretched 
follicle cells and completely surrounds each nurse cell. 
(B)  In CG31731Mi{MIC}/Mi{MIC} late-stage egg chambers, Draper enrichment in the 
stretched follicle cell membranes is scattered (arrowhead). Draper staining does not 
completely surround the nurse cells and is sometimes absent around the nurse cells 
(arrows).  
A 
 
 
 
 
 
 
 
 
B 
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Figure 3.22 CG31731 promotes acidification of the nurse cells 
                 
 
C 
 
A 
 
 
 
 
 
 
 
B 
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(A-B) Egg chambers, stained with LysoTracker (red) to label acidified compartments, 
and DAPI (blue) to label DNA, from WT or CG31731Mi{MIC}/Mi{MIC} mutants.  
(A)  WT (w1118) developing egg chambers show acidified nurse cells beginning stage 12, 
after dumping has completed, when majority of the nurse cells become LysoTracker-
positive. LysoTracker-positive staining of the nurse cell nuclei visibly corresponds to a 
reduction DAPI staining (arrows). By stage 13 when the dorsal appendages begin to 
form, only a few nurse cell nuclei stain with DAPI as almost all the nurse cells have been 
acidified. By stage 14, all the remaining nurse cells become LysoTracker-positive and no 
nurse cell nuclei can be detected in the DAPI channel. 
(B)  CG31731Mi{MIC}/Mi{MIC} stage 12-14 egg chambers exhibit a few nurse cells that  are 
LysoTracker-positive. The stage 12 egg chamber does not show any LysoTracker-
positive staining, while a few nurse cells in the stage 13 egg chamber are acidified. At 
stage 14, the persisting nurse cell nuclei are not LysoTracker-positive and can be detected 
in the DAPI channel. 
(C)  The percentage of egg chambers that exhibit nurse cells with LysoTracker-positive 
staining of all late stage egg chambers quantified per genotype. WT stage 11 (n=41), 
stage 12 (n=43), stage 13 (n=18), stage 14 (n=34), and CG31731Mi{MIC}/Mi{MIC} stage 11 
(n=26), stage 12 (n=47), stage 13 (n=18), stage 14 (n=68).  
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Figure 3.23 CG31731 is required in the follicle cells for engulfment of the germline 
material during starvation-induced PCD 
 
Healthy and dying egg chambers stained with anti-Dlg antibody (magenta) to label 
follicle cell membranes, anti-cleaved Dcp-1 antibody (orange) to label active caspases 
and apoptotic germline debris, and DAPI (cyan) to label DNA. In control (TM6B/UAS-
CG31731RNAi-GD1133) dying egg chambers, follicle cells normally enlarge from phase 1-5 
and engulfed Dcp-1-positive vesicles can be seen inside the follicle cells. In 
CG31731Mi{MIC}/- mutants or when CG31731RNAi-GD1133 is expressed specifically in the 
follicle cells (GR1-GAL4 G89/UAS-CG31731RNAi-GD1133), late phase dying egg chambers 
show severe engulfment defects with fewer engulfed Dcp-1 vesicles in phase 3, 
completely unengulfed germline and follicle cells with pyknotic nuclei and no membrane 
markers in phase 5. Engulfed nurse cell nuclei are indicated (arrowheads).   
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Figure 3.24 CG31731Mi{MIC}/Mi{MIC} mutants do not exhibit defects in neuronal cell 
clearance in the brain 
 
 
 
A brain from a CG31731Mi{MIC}/Mi{MIC} mutant stained with DAPI (cyan) to label DNA 
and TUNEL (green) to label fragmented DNA. DAPI staining shows predominantly 
neuronal nuclei with healthy dispersed chromatin and a single condensed, TUNEL-
positive, nucleus (n= 12). (Images acquired by Johnny Elguero)  
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4 CHAPTER 4: DISCUSSION AND FUTURE PERSPECTIVES 
 
4.1 Engulfment during programmed cell death 
The engulfment process is essential in a variety of tissues and organs to ensure the 
efficient removal of potentially deleterious dying and dead cells. In general, the removal 
process is performed by phagocytes which engulf the dead material. Extensive genetic 
studies in C. elegans, Drosophila, mice, and humans have illustrated a highly conserved 
engulfment mechanism regulated by two parallel signaling pathways, one involving ced-
1/-6/-7 and the other ced-2/-5/-12. Together, these components of the engulfment 
machinery promote vesicle delivery and cytoskeletal rearrangements for membrane 
extensions at the phagocytic cup. Currently, the orthologs for each of these core 
engulfment genes have been identified in each respective species, except for ced-7 in 
Drosophila. The work presented in this thesis characterizes the role of novel gene, 
CG31731, which appears to play a ced-7-like role in engulfment during PCD in the 
Drosophila ovary. 
4.2 CED-7/ABCA1 
The C. elegans ced-7 gene, and its mammalian homolog ABCA1, encode proteins 
of the ABCA class of transporters. Sequence analyses of ced-7/ABCA indicate they each 
possess 2 TMDs which can localize to membranes, and 2 NBDs which can hydrolyze 
ATP to translocate substrates across the membrane. Interestingly, while in ABCA1 the 
function of both NBDs is equally important (Luciani and Chimini, 1996), in CED-7 the 
first NBD appears to be more important than the second (Wu and Horvitz, 1998). To 
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date, the precise mechanism of transport in CED-7/ABCA1 remains elusive. The lack of 
collective data between these functionally equivalent ABC transporters has made it 
difficult to determine their precise roles during engulfment during PCD. 
Some studies in C. elegans suggest CED-7 promotes CED-10- mediated 
cytoskeletal rearrangements (Kinchen et al., 2005). How this may be achieved is unclear 
and this model is controversial (Mangahas and Zhou, 2005). Other studies in mammalian 
cell culture have demonstrated a requirement for ABCA1 in PtdSer exposure following 
an apoptotic stimulus (Hamon et al., 2000). Whether ABCA1 is expressed in dying cells 
in vivo, remains unknown. While CED-7 is reported to be required in both the phagocyte 
and the dying cell for efficient engulfment (Wu and Horvitz, 1998), it is not required for 
PtdSer exposure in dying cells in vivo (Mapes et al., 2012).  
With more consistency, CED-7/ABCA1 have both been shown to be required for 
CED-1/MEGF10 clustering at the phagocytic cup (Zhou et al., 2001; Hamon et al., 2006), 
which in C. elegans allows for the recognition of PtdSer on the surface of dying cells by 
CED-1 (Wang et al., 2010). Recently, CED-7 was also shown to promote the shuttling of 
vesicles, possibly containing engulfment recognition signals, from dying cells to 
phagocytic cells (Mapes et al., 2012), which correlates with the known role of ABCA1 
and also ABCA7 in mediating cholesterol and lipid efflux from the plasma membrane 
(Hamon et al., 2000; Wang et al., 2003). Furthermore, CED-7/ABCA1 have also been 
implicated in vesicle trafficking with DYN-1/Dynamin to deliver vesicles to the growing 
phagocytic cup (Yu et al., 2006), and to promote phagosome maturation and subsequent 
degradation of the cell corpse (Yu et al., 2008). All taken into consideration, these 
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observations suggest that CED-7/ABCA1 likely contributes several roles during 
engulfment and may have a role in cell corpse degradation.  
Most of the proposed activities of CED-7/ABCA1 involve the trafficking of 
lipids, suggesting they may act as lipid transporters. Indeed, ABCA transporters share a 
functional relation in lipid transport (Vasiliou et al., 2009). However, where exactly these 
unique transporters act to transport lipids, whether they export or import lipids across the 
membrane, and which types of lipids they transport during engulfment, remains unclear. 
4.3 CG31731 discussion and future perspectives 
   To our knowledge, prior to this study there have been no reports of a Drosophila 
functional equivalent for CED-7/ABCA. In this work, we show that CG31731 encodes an 
ABCA transporter similar to CED-7/ABCA1 that is required for engulfment during PCD. 
Sequence analyses of CG31731 indicates that the gene encodes an ABC transporter of the 
ABCA family that contains 2 membrane-spanning TMDs and 2 ATP-binding NBDs. 
Alignment of the predicted amino acid sequence of CG31731 with that of ced-7 and the 
mammalian counterpart ABCA1 found a substantial amount of similarity and identity 
between the polypeptides, especially in the catalytic NBD regions. Although CG1718 
showed a higher similarity and identity with ced-7 and ABCA1, suggesting that the gene 
is evolutionarily closer to ced-7 and ABCA1, we did not find an independent role for 
CG1718 during nurse cell clearance in the ovary, and a separate group similarly did not 
observe a role for CG1718 during neuronal corpse clearance in the brain (Ziegenfuss, 
2012). Instead, our experiments show that CG31731 is functionally more similar to CED-
7/ABCA1 during engulfment during PCD in the Drosophila ovary.  
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   We found that CG31731 mutants exhibit engulfment defects during 
developmental PCD in the ovary, as indicated by the persistence of uncleared nurse cell 
corpses in stage 14 egg chambers. Our genetic analyses show that CG31731 is required in 
the follicle cells for clearance of the nurse cells. Intriguingly, RNAi-mediated gene 
silencing of CG31731 specifically in the phagocytic stretched follicle cells did not disrupt 
clearance of the nurse cells, suggesting CG31731 is expressed earlier before the stretched 
follicle cells differentiate from the follicle cells after stage 8. While additional expression 
of CG31731 is not required in these specialized follicle cells, the CG31731 protein is 
likely present and required for the stretched follicle cell phagocytic function. In the 
future, to verify exactly in which cell types CG31731 is present, we hope to detect the 
protein via an antibody or endogenous tag.  
   In C. elegans, CED-7 was reported to be required in both the phagocytic cell and 
in the dying cell for efficient corpse clearance (Wu and Horvitz, 1998). Our studies in the 
Drosophila ovary observed a requirement for CG31731 in the phagocytic follicle cells, 
but not in the dying nurse cells. We knocked down CG31731 expression specifically in 
the germline and did not notice any apparent engulfment defects. Of the 3 available 
RNAi constructs, 2 encode long hairpin RNAs which are typically ineffective in the 
germline (Ni et al., 2011). 1 expresses short hairpin RNAs, which should efficiently 
facilitate knockdown in the nurse cells, however it is still possible that the knockdown 
was unsuccessful. Thus, we are currently generating homozygous CG31731 germline 
clones using the FLP/FRT ovoD system (Chou and Perrimon, 1996). The results from 
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these germline clones will reliably determine whether CG31731 also has a role in the 
dying nurse cells for their clearance. 
   In several experiments, we also attempted to over-express CG31731 using the 
P{EPgy2} UAS-enhancer construct. Unfortunately, our results from these experiments 
were often inconclusive and did not corroborate with our other findings. We speculate 
that the CG31731P{EPgy2} allele may not actually over-express the CG31731 gene. We 
have extracted RNA from the ovaries of GR1>CG31731P{EPgy2} mutants and plan to 
perform qRT-PCR to check the expression levels of CG31731 in these mutants compared 
to in WT ovaries. We also plan to perform qRT-PCR with RNA extracted from the 
ovaries of CG31731PBac/PBac, CG31731Mi{MIC}/Mi{MIC}, and CG31731Mi{MIC}/- mutants. Our 
data suggest the CG31731PBac/PBac mutant is a weak hypomorph while the 
CG31731Mi{MIC}/Mi{MIC} mutant is a strong hypomorph. In theory the Mi{MIC} insertion 
should generate a null mutation in the gene. We hope to validate the expression of 
CG31731 in these mutants via qRT-PCR. If we find that the CG31731Mi{MIC}/Mi{MIC} 
mutant is a null, this would suggest that other genes affected in the deficiency allele are 
contributing to the more severe engulfment defect in CG31731Mi{MIC}/- mutants. In such a 
case, it would be interesting to pursue other genes missing in the deficiency and perhaps 
identify other novel components of the engulfment machinery. 
 Core components of the engulfment machinery identified in Drosophila include 
Draper/Ced-6 and Crk/MBC/Ced-12. Our double mutant analyses of 
CG31731Mi{MIC}/Mi{MIC} with draperΔ5or Ced-12RNAi, demonstrate that CG31731 likely acts 
in the same pathway as draper and in parallel to Ced-12. Indeed, in C. elegans and 
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mammals CED-7/ABCA1 is known to act in the same pathway as CED-1/MEGF10 and 
parallel to CED-12/ELMO (Mangahas and Zhou, 2005; Hamon et al., 2006). These 
results suggest CG31731 may serve as the functional equivalent for CED-7/ABCA1 in 
the Draper pathway. We also found a role for CG1718 when CG31731 is disrupted. Our 
data show evidence of a compensatory relationship between CG1718 and CG31731 
during removal of the nurse cells in developmental PCD. Since both genes encode ABC 
transporters of the same ABCA family, which are known to share a functional 
relationship in lipid trafficking, it may not be too surprising that the proteins may be able 
to compensate for one another. In mammals, ABCA1 and ABCA7 have been observed to 
provide homologous functions, especially in lipid homeostasis (Hamon et al., 2000; 
Wang et al., 2003). Therefore, we speculate that in the lack of CG31731, CG1718 may 
provide a CG31731-like function during nurse cell clearance in the ovary. 
 Curiously, the CG1718miR-1007-KO/miR-1007-KO mutant, which provided evidence of 
genetic redundancy between CG1718 and CG31731, specifically carries a null mutation 
in the miR-1007 gene, and microRNAs are known to also influence lipid metabolism and 
cell death (Ambros, 2003). It is not obvious whether the engulfment defect we observed 
identifies a role for CG1718 or for miR-1007. Additional experiments are needed to 
clarify this dilemma. A relatively straightforward experiment would be to simultaneously 
silence CG1718 and CG31731 gene expression without affecting miR-1007 expression. 
Conveniently, there are several CG1718 RNAi constructs readily available to specifically 
knockdown only the CG1718 transcripts. The results from these experiments would 
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provide additional evidence as to whether CG1718 can genetically compensate for the 
lack of CG31731 in nurse cell clearance. 
 Multiple investigations in C. elegans and mammals have repeatedly observed a 
role for CED-7/ABCA1 in lipid transport (Hamon et al., 2000; Wang et al., 2010; Mapes 
et al., 2012). Attractively, CG1718 was previously implicated in lipid metabolism and 
speculated to play a similar role to ABCA1 in lipid efflux (Bujold et al., 2010). While we 
did not find an independent role for CG1718 in nurse cell clearance, our data suggest a 
genetic redundancy for CG31731, supporting a hypothetical role for CG31731 in lipid 
transport. Thus by analogy, CG31731 may function as a lipid transporter. In support of 
this hypothesis, CG31731 is expressed at very high levels in the larval fat bodies 
(Flybase). Additionally, in CG31731 mutant egg chambers, follicle cells fail to properly 
extend their membranes, perhaps because the delivery of vesicles containing lipids to the 
growing follicle cell membrane is disrupted, resulting in insufficient membrane 
extensions. Indeed, CED-7 has been implicated in intracellular vesicle delivery to the 
phagocytic cup (Yu et al., 2006), and ABCA1 has been demonstrated to shuttle lipids 
albeit to extracellular HDLs (Hamon et al., 2000). To further investigate a potential role 
for CG31731 in lipid transport, it would be useful to determine the membranes to which 
CG31731 localizes, possibly with an antibody or an endogenous tag, and observe any 
changes in lipid distribution across these membranes. It would also be interesting to 
visualize the abundance of lipid vesicles, perhaps with Oil Red O staining, in WT versus 
CG31731 mutant egg chambers. The data from these experiments may provide more 
concrete evidence to determine a role for CG31731 in lipid trafficking. 
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 An equally important question concerns the specific substrates – if lipids, then 
what type of lipids, are transported by CED-7/ABCA1 and CG31731? In vitro mouse cell 
culture experiments have suggested that ABCA1 may act as a floppase to transport 
PtdSer from the inner leaflet to the outer leaflet in apoptotically dying cells (Hamon et 
al., 2000). However, PtdSer exposure on the surface of dying cells in vivo does not 
require CED-7 in C. elegans (Mapes et al., 2012). Perhaps a different approach to 
determine the substrate would be to define the direction of transport, specifically whether 
these proteins function as exporters or importers. While not ideal, these experiments may 
be more easily carried out in vitro in cell culture. Since more is known about the 
distribution of lipids across healthy versus dying cells, if these ABC transporters are 
transporting lipids, knowing which direction they may be transporting lipids would 
provide a clue to its specific lipid substrate, and thereby how their activity contributes to 
PCD.  
 CED-7/ABCA1 has been demonstrated to promote CED-1/MEGF10 clustering at 
the phagocytic cup (Zhou et al., 2001; Hamon et al., 2006). Similarly, we observed a 
requirement for CG31731 in Draper enrichment and accumulation around the dying nurse 
cells. Draper staining in egg chambers from CG31731Mi{MIC}/Mi{MIC} mutants showed a 
lack of Draper enrichment in the stretched follicle cells, scattered Draper staining around 
some nurse cell nuclei, and absent Draper staining around other nuclei. We wonder 
whether in these mutants Draper fails to cluster at the phagocytic cup or the stretched 
follicle cells fail to extend and surround all the nurse cells. In other engulfment defective 
mutants we have previously characterized, the stretched follicle cells can fail to surround 
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some nurse cells (Timmons et al., 2016). Moving forward, we plan to express an 
endogenous mCD8-GFP marker specifically in the stretched follicle cells, to observe the 
location of the stretched follicle cells in CG31731Mi{MIC}/Mi{MIC} mutants. 
 Previous work from our lab has shown that in draperΔ5mutants, acidification of 
the nurse cells is dramatically blocked (Timmons et al., 2016). We deduced that since 
Draper enrichment is depressed in CG31731Mi{MIC}/Mi{MIC} mutants, perhaps nurse cell 
acidification may also be disrupted. Indeed, LysoTracker staining of late stage egg 
chambers from CG31731Mi{MIC}/Mi{MIC} mutants indicate that while acidification is not 
blocked, it is delayed in developing egg chambers. Attractively, a similar defect is 
observed in C. elegans wherein null mutations in the pathway not only delay and block 
the engulfment of some corpses, but also delay the degradation of engulfed apoptotic 
material. The same studies also demonstrate a role for CED-7 in intracellular endosome 
trafficking and RAB-7 enrichment on the surface of phagosomes (Yu et al., 2006; Yu et 
al., 2008). Thus, perhaps in CG31731Mi{MIC}/Mi{MIC} mutants, trafficking of the lysosomal 
machinery for acidification of the nurse cells is disrupted. Consistent with this 
hypothesis, ABCA1 is observed to localize to the Golgi stacks, plasma membrane, and 
endolysosomal vesicles (Hamon et al., 2000), dynamic compartments which are involved 
in both engulfment and lysosomal degradation events. How the nurse cells become 
acidified and subsequently degraded is currently under investigation in our lab. It would 
be interesting to also pursue how the lysosomal machinery is disrupted in CG31731 
mutant follicle cells. Future experiments to elucidate this question could involve 
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monitoring the activity of proteins involved in lysosomal acidification events, including 
V-ATPases, LAMP, Shibire, Rab5 and Rab7, in CG31731Mi{MIC}/Mi{MIC} egg chambers. 
 In C. elegans, CED-7 has been shown to have a role during engulfment in 
multiple PCD systems in vivo. We wondered whether CG31731 may also be involved in 
other PCD systems in Drosophila. Conveniently, a distinct PCD modality from 
developmental PCD in late oogenesis can be easily induced via protein starvation in mid-
oogenesis. While in late stage developmental PCD the nurse cells die via phagoptosis 
(Timmons et al., 2016), in mid-stage starvation-induced PCD the nurse cells die via 
apoptotic and autophagic cell death pathways (Jenkins et al., 2013). Engulfment of the 
nurse cells in both PCD systems are regulated similarly by components of the draper and 
Ced-12 pathways (Timmons, 2015). From our studies in late oogenesis, we selected the 
CG31731 mutants which exhibited the most severe phenotypes and looked for 
engulfment defects in mid-oogenesis. As we anticipated, mid-stage dying egg chambers 
from CG31731Mi{MIC}/- mutants exhibited engulfment defects in follicle cells that fail to 
enlarge normally and die prematurely, leaving behind egg chambers with unengulfed 
germline debris. We observed a similar phenotype when CG31731RNAi-GD1133 was 
expressed specifically in the follicle cells, but not when CG31731RNAi-GD1133 or 
CG31731RNAi-HMC06027 was expressed specifically in the nurse cells. These observations 
are similar to our data in late oogenesis, in which CG31731 appears to primarily act in 
the engulfing follicle cells to regulate clearance of the dying nurse cells.  
 Of specific personal interest is the manner by which the follicle cells disappear in 
engulfment defective mid-oogenesis mutants. In WT mid-stage dying egg chambers, once 
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the follicle cells have completed engulfment of the germline debris, they similarly lose 
membrane markers, display pyknotic nuclei, and eventually disappear. Over-expression 
of the Drosophila inhibitor of apoptosis (Diap1) or the p35 caspase inhibitor specifically 
in the follicle cells does not prevent the follicle cell nuclei from becoming pyknotic, 
indicating the follicle cells do not die via apoptotic mechanisms (Etchegaray et al., 2012). 
There is evidence to suggest that the follicle cells die via autophagic cell death pathways, 
for example under starved conditions, the follicle cells upregulate autophagy machinery 
(Barth et al., 2011). Moreover, the lack of ATG genes, including in atg7d14/d77 mutants, 
results in dying egg chambers which exhibit a significant quantity of uncleared pyknotic 
follicle cells (unpublished observation, Jeanne Peterson). These observations suggest that 
the autophagic cell death pathway may have a role in the clearance of follicle cell 
corpses. From these pieces of data, we postulate that perhaps in starvation-induced mid-
stage dying egg chambers, as a result of insufficient nutrients the follicle cells normally 
uptake the dying germline in an attempt to recycle its degraded material. However, in 
engulfment defective mutants, the follicle cells do not efficiently uptake the germline and 
therefore prematurely activate autonomous autophagic cell death mechanisms as an 
adaptive response. At this time, these hypotheses remain highly speculative. What exactly 
regulates the death and clearance of the follicle cells has not been well studied. 
 We also looked for a role for CG31731 outside the ovary, specifically in the 
Drosophila brain where engulfing glia are responsible for neuronal corpse clearance. Our 
observations in CG31731Mi{MIC}/Mi{MIC} mutants did not observe any accumulation of 
uncleared neuronal corpses in the brain, suggesting CG31731 does not play a prominent 
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role during engulfment in the brain. We speculate that perhaps there is another ABCA 
gene that provides a ced-7-/ABCA1-like role in engulfing glia. Nevertheless, we are still 
exploring potential roles for CG31731 in other PCD systems. Fascinatingly, CG31731 is 
expressed highest in the white prepupal salivary glands (Flybase), which undergo 
massive cell death during development. It was found that in E93 mutants, which exhibit 
salivary glands that fail to undergo PCD, CG31731 expression is downregulated (Dutta, 
2008). These pieces of information suggest a role for CG31731 in PCD of the salivary 
glands, thus we are currently investigating this hypothesis. 
 To date, the precise molecular mechanism by which CED-7/ABCA1 promotes 
engulfment during PCD has yet to be determined. Several other questions, including why 
the catalytic function of each NBD appears to be differentially important between CED-7 
and ABCA1, despite these transporters contributing homologous roles in engulfment, and 
how ATP is used to catalyze the conformational changes that allow transport, remain 
unanswered. In general, the mechanism of transport in ABC transporters is controversial. 
Our characterization of CG31731 provides another ABC transporter to elucidate not only 
the molecular mechanisms of its C. elegans and mammalian counterparts, CED-
7/ABCA1 in engulfment, but also that of ABCA transporters in general. 
 In conclusion, the results and discussions outlined in this thesis provide insight 
into the molecular activities that occur during engulfment in PCD, with specific attention 
to the role of ABCA transporters. We have identified CG31731, a ced-7/ABCA1-like 
ABCA transporter gene that is required during engulfment in the Drosophila ovary. 
Moreover, we have evidence of some genetic redundancy with another ABCA transporter 
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gene, CG1718. To our knowledge, this is the first reporting of a role for ABCA 
transporters in PCD in Drosophila. We hope that our identification of at least one 
putative ced-7/ABCA1 homolog in the Drosophila will advance the study to elucidate the 
functions and molecular mechanisms of this unique class of transporters during PCD in 
vivo. 
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